The Dose-Response Association of Physical Activity and the Metabolic Syndrome Among U.S. Adults: NHANES 1999-2004 by Churilla, James R.
University of Tennessee, Knoxville 
TRACE: Tennessee Research and Creative 
Exchange 
Doctoral Dissertations Graduate School 
5-2007 
The Dose-Response Association of Physical Activity and the 
Metabolic Syndrome Among U.S. Adults: NHANES 1999-2004 
James R. Churilla 
University of Tennessee, Knoxville 
Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss 
 Part of the Sports Sciences Commons 
Recommended Citation 
Churilla, James R., "The Dose-Response Association of Physical Activity and the Metabolic Syndrome 
Among U.S. Adults: NHANES 1999-2004. " PhD diss., University of Tennessee, 2007. 
https://trace.tennessee.edu/utk_graddiss/4230 
This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee 
Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized 
administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact 
trace@utk.edu. 
To the Graduate Council: 
I am submitting herewith a dissertation written by James R. Churilla entitled "The Dose-
Response Association of Physical Activity and the Metabolic Syndrome Among U.S. Adults: 
NHANES 1999-2004." I have examined the final electronic copy of this dissertation for form and 
content and recommend that it be accepted in partial fulfillment of the requirements for the 
degree of Doctor of Philosophy, with a major in Exercise Science. 
Eugene C. Fitzhugh, Major Professor 
We have read this dissertation and recommend its acceptance: 
Edward T. Howley, Dixie L. Thompson, David R. Bassett, Lisa Jahns 
Accepted for the Council: 
Carolyn R. Hodges 
Vice Provost and Dean of the Graduate School 
(Original signatures are on file with official student records.) 
To the Graduate Council: 
I am submitting herewith a dissertation written by James R. Churilla entitled "The 
Dose-Response Association of Physical Activity and the Metabolic Syndrome 
Among U.S. Adults: NHANES 1999-2004." I have examined the final paper copy 
of this dissertation for form and content and recommend that it be accepted in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy, with 
a major in Exercise Physiology. 
We have read this dissertation 
and recommend its acceptance 
l.d�J.� 
Edwfj"d T. Howley, PM 
JYU7/t,Jd_ 
y 
Dixie L. Thompson, Ph.D. 
Eugene C. Fitzhugh, Ph.D., Maj r Professor 
i}J y� ,Jn. 
Accepted for the Council: 
�'ff-� 
Vice Provost and Dean of the 
Graduate School 

THE RELATIONSHIP BETWEEN LEISURE-TIME PHYSICAL ACTIVITY AND 
THE METABOLIC SYNDROME AMONG U.S.ADULTS: 1999-2004 NHANES 
Presented for the Doctor of Philosophy Degree 
The University of Tennessee, Knoxville 




To Mirtha, my wife, and Cameron and Tyler, my two sons. Knowing your love 
and support was always there, made this journey worth it. This is ours. 
To my departed brother-in-law Johnny, this world will never truly reach its 
potential without you. 
ii 
ACKNOWLEDGEMENTS 
I would like to thank Dr. Eugene C. Fitzhugh for being my graduate advisor 
during my doctoral studies at Tennessee. I am greatly appreciative of his 
mentorship and friendship throughout my entire journey. His strong 
epidemiological skills and passion for the field made me work as hard as I could 
toward becoming a competent physical activity epidemiologist. I am extremely 
grateful for all of the time he invested in developing me. 
I would like to also thank Dr. Edward T. Howley for always having an open 
door policy and his tremendous contribution to the field of exercise physiology, 
he is truly a pioneer. Thank you Dr. Dixie L. Thompson for your contribution to 
my work and for believing in me. Thank you Dr. David R. Bassett, Jr. for bringing 
me to Tennessee and your guidance throughout my studies. I would also like to 
thank Dr. Lisa Jahns for taking time to serve on my committee. 
There are many others that deserve appreciation and will not be forgotten. I 
would like to thank Kathryn Meunier for all her assistance during my time here at 
Tennessee. A special thanks to Scott Crouter who made my first year more 
bearable and has since been a reliable resource and friend. Thanks to Pam 
Andrews for all her assistance in the laboratory. Amber McMahan, Tracy Swibas, 
Erin Kuffel, and Dinesh John, thank you for your friendship. 
Lastly, I would like to thank Mirtha, Cameron, and Tyler for letting me be 
both JC and Dad. My Mother and Father for always being there to support me 
through the good and bad. And Terri, my sister, who is a special person in my 
fife. Thanks to all. 
iii 
ABSTRACT 
The purpose of this study was to evaluate the current prevalence of 
the metabolic syndrome with an emphasis on examining the relationship 
between leisure time physical activity (L TPA) and the metabolic syndrome 
in a nationally representative sample of the United States (U.S.) adult 
population within the 1999-2004 National Health and Nutrition 
Examination Survey (NHANES). The sample for.this study included adults 
(N=5620), 20 years and older, who attended a mobile examination center 
(MEC) examination in the NHANES 1999-2004. The American Heart 
Association and National Heart, Lung, and Blood Institute (AHA/NHLBI) 
AHA/NHLBI definition was used to define the metabolic syndrome based 
on the results of a preliminary pilot study found in Appendix A. A metabolic 
syndrome risk score (MSRS), ranging from Oto 5 was created to sum 
cardiovascular (CV) risk factors. Accumulating a MSRS ?_3 designated a 
metabolic syndrome diagnosis, a dependent variable within this study. 
Physical activity (PA) was measured in two ways; a six-level measure of 
MET·minutes per week, comprised of PA frequency, intensity, and 
duration and a three-level variable (no leisure-time physical activity 
(L TPA), insufficient L TPA, and an L TPA level equivalent to meeting the 
CDC/ACSM PA recommendation) associated with the current Centers for 
Disease Control and American College of Sports Medicine public health 
PA recommendation (CDC/ACSM). SUDAAN statistical software was 
iv 
used to estimate age-adjusted prevalence and logistic and multi-logistic 
odds risk ratios. 
The overall age-adjusted prevalence of the metabolic syndrome 
among the U.S. adult population was 36.3%. A significant difference was 
found for metabolic syndrome prevalence between those meeting the 
current public health PA recommendation (29.0%) and those reporting no 
L TPA (40.0%). Adults who acquired between 736.55 and 1360.15 
MET·min·wk-1 of L TPA were found to be 35% (OR 0.65; 95% Cl 0.48-0.88) 
less likely to meet the AHA/NHLBI metabolic syndrome diagnosis criteria 
compared to those reporting no L TPA. A similar inverse association was 
found for an increasing the MSRS (OR 0.69; 95% Cl 0.56..;0.85)_. The 
strength of this inverse association increased (OR 0.55; 95% Cl 0.42-0.71) 
when weekly L TPA MET·minutes reached >1360.15 MET·min·wk-1. This 
inverse association was also found for an MSRS (OR 0.58; 95% Cl 0.48-
. 0.70) at this level of LTPA. 
These findings estimate one in three U.S. adults have the metabolic 
syndrome. This study consistently showed an inverse association between 
L TPA and metabolic syndrome risk. Furthermore, there appeared to be a 
stronger inverse association between metabolic syndrome and LTPA 
when L TPA volume was increased. However, this additional decrease in 
risk associated with increasing volumes of L TPA may likely revolve around 
improvements in body composition. Improvements in body composition 
associated with varying frequencies, intensities, and duration of PA may 
V 
improve other components defining the metabolic syndrome (i.e. 
hypertension, obesity.) While this study is cross-sectional and causality 
cannot be inferred due to the nature of self-reported data, our findings do 
illustrate a strong inverse association for L TPA and the metabolic 
syndrome. Researchers can feel confident that if L TPA is measured using 
all three components (frequency, intensity, and duration) necessary to 
calculate MET·min·wk-1, that relationships with the metabolic syndrome 
and its individual defining criteria will be detected. These results support 
the need for future longitudinal studies and randomized control trials 
examining PA volume and metabolic syndrome risk. 
vi 
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The clustering of multiple cardiovascular risk factors was first observed by 
Kylin (3 1) in 1 923, when the Swedish physician reported three medical conditions 
occurring together that he characterized as a syndrome. These conditions 
included hypertension (HTN), hyperglycemia, and hyperuricemia. However, it 
was not until 1 988 (42) that cardiovascular (CV) risk factor clustering became a 
common focus for researchers. At this time, Reaven (42) described a series of 
abnormalities called "Syndrome X", which included insulin resistance ( IR), 
glucose intolerance, hypertension (HTN), hyperinsulinemia, elevated very low­
density lipoprotein (VLDL) triglycerides, and low high-density lipoprotein 
cholesterol (HDL-C) . Today, this constellation of cardiovascular risk factors which 
now includes abdominal obesity (29) , is commonly known as the metabolic 
syndrome, and is recognized as a global public health problem (51 ). 
The metabolic syndrome has been shown to contribute to premature 
morbidity and mortality resulting from cardiovascular disease (CVD) and type 2 
diabetes (T2D), two of the leading causes of death worldwide (26, 38, 45). With 
this in mind, the United States (U .S .) medical community recognized the 
importance of diagnosing the metabolic syndrome by creating the International 
Classification of Disease ( IC0-9) Code .277.7 for the Dysmetabolic syndrome 
(1 3) . 
Despite the recognition by the medical community, only recently has the 
prevalence of the metabolic syndrome in the U .S. population been widely 
reported (1 5-1 7) . In fact, the first definition of the metabolic syndrome was 
published by the World Health Organization (WHO) (4 7) in 1 999. Since the 
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creation of the WHO definition, there have been several definitions of the 
metabolic syndrome published by various medical societies (1 , 1 3, 20, 24, 39). 
Nevertheless, the core components are similar across all definitions and include: 
IR or type 2 diabetes (T20), central obesity, HTN, and atherogenic dyslipidemia 
(elevated triglycerides and low levels of high-density lipoprotein cholesterol 
(HDL-C)). The most recent definition of the metabolic syndrome has been 
developed by the American Heart Association (AHA) and the National Heart, 
Lung and Blood I nstitute (NHLBI) (20), and represents an updated version of the 
National Cholesterol Education Program (NCEP) (39) definition. To date, no 
study has estimated the prevalence of metabolic syndrome according to the 
AHA/NHLBI definition . 
Central to these metabolic syndrome definitions are factors highly 
associated with lifestyle, including smoking, alcohol consumption, diet, and 
physical activity (PA). The positive impact regular PA has on cardiovascular risk 
and overall health is well recognized (9) .  The Centers for Disease Control ar:,d 
Prevention (CDC) and the American College of Sports Medicine (ACSM) have 
established the public health recommendation that all Americans should 
accumulate a minimum of 30 minutes of moderate-intensity PA on most if not all 
days of the week or 20 minutes of vigorous-intensity PA on three days per week 
(41). With this PA recommendation in mind, researchers have focused on the 
impact of PA on individual CV risk factors (2, 21, 44, 48, 49). However, the first 
study examining the association of PA with the clustered risk factors of the 
metabolic syndrome was not conducted until 1998, when Wareham et al. (46) 
3 
reported that increasing total physical activity energy expenditure (PAEE) 
reduced the risk (OR 0.32, 95%CI, 0.13-0.83) of the metabolic syndrome. 
· Over the last decade, the body of literature examining the relationship 
between PA and the risk of the metabolic syndrome has flourished. Several 
cross-sectional (3, 5, 11, 12, 18, 19, 21, 22, 25, 28, 34-37, 40, 43, 50) and 
longitudinal studies (4, 14, 27, 30, 32, 33) have been conducted. An all important 
question within this literature is examining the relationship between the volume of 
PA and the potential risk reduction of the metabolic syndrome. The frequency, 
intensity, and duration of PA are the characteristics used to express the volume 
of PA necessary to elicit a certain response (23) . To date, only four studies (11, 
18, 49, 50) have investigated the relationship between PA and the metabolic 
syndrome using a national representative sample of U.S. adults. However, none 
of these studies included data on all the components of PA volume (frequency, 
duration, and intensity) necessary to fully examine the association of PA with the 
risk of having the metabolic syndrome. 
In _ the first study, which utilized the 1988-1994 Third National Health and 
Nutrition Examination Survey (NHANES Il l) dataset, Park et al. (40) used a 
physical activity intensity score (PAIS) to define physical inactivity while 
examining the relationship between being inactive and having or not having the 
metabolic syndrome. Individuals with a PA intensity score � 3.5 were designated 
physically inactive and comprised 15 and 25 percent of adult males and females 
respectively, in the U.S. population. In a multivariate odds ratio (OR) model 
adjusting for ethnicity, BMI, smoking status, alcohol intake, carbohydrate intake, 
4 
education level, household income, and menopausal status, neither men (OR 
1 .4;  95% Cl 1 .0-2.0) or women (OR 1 .2 ,  95% Cl 1 .0-1 .4) classified as physically 
inactive were found to be at an increased risk for having the metabolic syndrome.  
This suggests there is no relationship between physical inactivity and the 
metabolic syndrome. 
I n  the second study utilizing the same NHANES I ll dataset, Zhu et al. (50) 
examined the relationship of being active, moderately active, and sedentary with 
the likelihood of having the metabolic syndrome as defined by National 
Cholesterol Education Program (NCEP) in U .S. adults. Based on a PAIS, which 
summated the weekly intensity in metabolic equivalents (METs) for each activity 
performed to get an overall total MET score. Physical activity levels were defined 
as follows: �1 5.0 (active), 3.6 to 1 4.9 (moderately active), and � 3.5 sedentary. 
Both males and females in the active group were found to be significantly less 
likely to have the metabolic syndrome compared to the inactive group (OR, 0.41 ; 
95% Cl 0.31 -0.54) for males and (OR, 0.25; 95% Cl 0.1 8-0.37) for females. 
Following adjustments for BMI , males were 73% less likely (OR 0.27, 95% Cl, 
0.1 8-0.40) and females were 68% less likely (OR 0.32; 95% Cl, 0.21 -0.51 ) to 
have the metabolic syndrome if they reported being active. 
Additionally, Zhu et al. found that men and women who reported being 
moderately active were 34% less likely (OR 0;66; 95% Cl, 0.48-0.89) and 31 % 
less likely (OR 0.69; 95% Cl, 0.48-0.99) respectively, to have the metabolic 
syndrome. However, among females, ·after adjusting for age, race, education ,  
income, and menopausal status in  the model, the relationship with PA 
5 
disappeared. While these findings in both the studies by Park et al. and Zhu et al. 
illustrate an inverse relationship between PA and the metabolic syndrome, data 
on the duration was not measured in NHANES I l l ,  so quantifying PA volume was­
not possible. 
In the third, which also used the NHANES I ll dataset, Du Bose et al. (11) 
examined the relationship between PA and the metabolic syndrome by defining 
PA with a three-level categorical variable, (inactive, irregularly active, and 
regularly active) and metabolic syndrome based on the NCEP medical society 
definition. Respondents acquiring � 5 d/wk of moderate PA for 30 minutes and/or 
� 3 d/wk of vigorous PA for 20 minutes were considered regularly active, those 
who reported some PA, however not � 5 d/wk of moderate or � 3 d/wk of 
vigorous PA, were considered irregularly active. Participants who reported no PA 
over the last 30 days were considered inactive. I rregularly active and inactive 
men were found to be 52% (OR 1.52; 95% Cl, 1. 11-2.31) and 60% (OR 1.60; 
95% Cl , 1 .18-1 .98), respectively, more likely to have the metabolic syndrome 
. compared to regularly active men following adjustment for age, race, gender, and 
education. In contrast, in women, physical inactivity was not found to be 
associated with increasing risk of having the metabolic syndrome (OR 0.96 ; 95% 
Cl 0.72-1.27) irregularly active and (OR 1. 18 ;  95% Cl 0.87-1.59) inactive. ·These 
findings specific to women were consistent with previous studies (25, 33 , 40). 
In the most recent study examining the relationship between PA and the 
metabolic syndrome, Ford et al. (18) utilized the 1999-2000 NHANES dataset ·(6) 
and included 1,626 subjects � 20 years of age who reported in a fasting condition 
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for a morning medical examination. During this examination, subjects were asked 
to report the frequency and duration that they spent performing 43 different 
leisure-time physical activities (L TPA) of moderate or vigorous intensity over the 
previous 30 days (6). The total PA time in minutes per week (min/wk) was 
calculated by summing the weekly minutes of participation for each intensity level 
L TPA. A three-level categorical variable was then created: O min/wk, < 150 
min/wk, and :: 150 min/wk. 
In this study, after only controlling for age, adults who were physically 
inactive were found to be 65% (OR 1.65; 95% Cl, 1.01-2.65) more likely to have 
the metabolic syndrome than those reporting :: 150 min/wk of PA. However, after 
controlling for gender, ethnicity, education, smoking status, and alcohol intake 
this association was attenuated to the point of non-significance (OR 1.45; 95% 
Cl, 0.86-2.44), yet when stratified by gender, women reporting no PA were over 
twice as- likely to have the metabolic syndrome when compared to women · 
reporting :: 150 min/wk.(OR 2.35; 95% Cl, 1. 19-4.63). Physical inactivity was not 
associated with the metabolic syndrome risk in men. 
While the research described above illustrates the relationship between 
PA and the metabolic syndrome, each study measured PA volume with only two 
of the necessary three components. More specifically, the duration of each bout 
of PA was not available in NHANES I ll (10), thus one of the necessary 
components for more accurately assessing PA volume was missing. Also, the 
investigators elected not to use available data on intensity (MET) level for each 
specific activity in the1999-2002 NHANES dataset. 
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An opportunity now exists to more accurately measure PA volume and its 
relationship with the metabolic syndrome using the most comprehensive 
measure of PA ever available in a nationally representative sample of U.S. 
adults. This measure, MET minutes per week (MET·min·wk-1) includes all the 
necessary components to measure L TPA volume: frequency, intensity, and 
duration. With this in mind, the purpose of this study was to estimate the current 
prevalence of the metabolic syndrome while examining the relationship of L TPA 
- ·with the metabolic syndrome using the most recent six years in1 999-2004 
NHANES (7). 
Statement of the Problem 
This study estimated the most recent prevalence of the metabolic 
syndrome using a nationally representative sample of U.S. adults utilizing the 
AHA/NHLBr definition. In addition, the relat1onship between L TPA and the risk of 
the metabolic syndrome was examined. Particular emphasis was placed on the 
relationship between L TPA and the metabol ic syndrome uti l izing MET-min·wk-1 , a 
more comprehensive measure of PA volume. Toward this end, these specific 
research questions are posed below. 
Research Questions 
1. What is the current prevalence of the Metabolic Syndrome in the 
United States adult population according to the American Heart 
Association/National Heart, Lung, and Blood Institute definition? 
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2. Is there an inverse association for L TPA and the metabolic syndrome 
when utilizing a measure of. L TPA volume (MET-min·wk-1)? 
3. Is there an inverse association for LTPA and the metabolic syndrome 
when measuring L TPA from the parameters of the CDC/ACSM 
physical activity public health recommendation? 
Significance of the Study 
The purpose of this study is to examine the relationship between L TPA 
and the Metabolic Syndrome metabolic syndrome in a nationally representative 
sample of the U.S. adult population. This will be the first study to estimate the 
current prevalence of the metabolic syndrome utilizing the AHA/NHLBI definition. 
Delimitations 
This study population was limited to U.S. adults aged 20 years and over 
who participated in a fasting morning medical examination and health interview in 
the1999-2004 NHANES (7). The NHANES is a collaborative effort between the 
National Center for Health Statistics (NCHS) and the Centers for Disease Control 
and Prevention (CDC) and is designed to provide national estimates of health 
and nutritional status of the civilian noninstitutionalized population of the U.S. 




Aspects of the1999-2004 NHANES may limit the findings in this study, 
therefore the findings and discussion of the findings in this study must be 
interpreted with caution. The limitations of this study are _described below. 
1 .  This was a cross-sectional study, thus causality cannot be established. 
2. Data on PA and all covariates were measured by a self-report interview, 
thus frequency, intensity, and duration of L TPA is subject to recall bias. 
3. Leisure-time physical activity, smoking, and alcohol responses may have 
been subjected to the social desirability effect (i. e. providing answers to 
impress or please interviewer). 
4. Dietary factors (i. e. ,  caloric intake) were controlled in _this study due to -the 
complex nature of this data inherent to 1999-2004 NHANES. 
10 
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PART II 
REVIEW OF LITERATURE 
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The metabolic syndrome (MetS) has been recognized as a global public 
health problem that is strongly linked as a seminal cause of cardiovascular 
disease (CVD) and type 2 diabetes (T2D), both of which are responsible for 
premature mortality and morbidity worldwide (108, 153, 207). The Mets is 
characterized by the clustering of cardiovascular risk factors including insulin 
resistance ( IR or T2D), central obesity, hypertension (HTN), and atherogenic 
dyslipidemia (elevated triglycerides and low levels of high-density lipoprotein 
cholesterol (HDL-C)) (14, 65, 103, . 155, 223). Also, depending on the medical 
society definition applied, microalbuminuria may also be considered another risk 
factor (223). 
The following review of the literature will discuss 1) a historical perspective · 
of cardiovascular risk factor clustering and the evolution of the Mets; 2) the most 
commonly used working medical society definitions of the Mets ; 3) current 
international and national prevalence estimates of the Mets; 4} the effects that 
physical activity (PA) (or lack thereof) has on the individual components of the 
Mets; and 5) review of all the studies done to date that have examined the 
association of PA with the Mets, both cross-sectional and longitudinal. 
Cardiovascular risk factor clustering and the metabolic syndrome 
The constellation of metabolic risk factors and their deleterious effects on 
cardiovascular health are well established (29, 84, 88, 141, 173, 229). Seminal 
risk factor clustering for cardiovascular disease (CVD) was first reported by Kylin 
(128) in the early 20th century. The Swedish physician described a syndrome 
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involving the clustering of HTN, hyperglycemia and hyperuricemia (gout). 
Subsequent work by Vague (212) reported a relationship between central 
adiposity and diabetes, and Avogaro (11 ), adding obesity to Kylin's original 
syndrome, strengthened the relationship between the clustering of Mets risk 
factors and CVD. With continued interest on risk factor clustering and CVD, 
Camus (35) coined an ensemble of CVD risk factors the 'deadly quintet' and 
Jahnke (111) referred to a 'special metabolic syndrome ' in specific individuals. 
For the first time in 1977, Haller and colleagues (91, 194) applied the term 
"metabolic syndrome" when examining the convergence of obesity, diabetes 
hyperproteinemia, hyperuricemia, and hepatic steatosis (fatty liver). 
Reaven (173) drew immense attention to risk factor clustering and CVD in 
his 1988 'Banting Lecture'. Frederick G. Banting was a Nobel Prize winning 
physician who was one of the two men responsible for the discovery of insulin 
(158). The 'Banting Lecture' is given every year by an expert in the area of 
diabetes at the annual meeting of the American Diabetes Association (6). 
Reaven described a constellation of risk factors leading to development of T2D 
and CVD which he termed Syndrome X. Reaven postulated the etiology and 
clinical course of three major related diseases - T2D, CVD, and HTN, all having a 
common foundation of IR and hyperinsulinemia. However, at this time, adiposity 
was not considered a major etiological factor. 
In 1989, Kaplan (115) coined the term The Deadly Quartet to describe 
upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. 
However, this- addition of central adiposity was not novel. It was established 60 
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years ago that upper-body obesity was a major player in the risk of developing 
CVD (212). Subsequent work found that this quartet of conditions had a high 
level of agreement more commonly than by chance (5, 115). 
Hypertriglyceridemia, HTN, and T20 have been found to be much more 
prevalent in obese compared to nonobese individuals (196, 213). Modan et al. 
(151) found a twofold increase in obesity and T2D among individuals with HTN 
versus their normotensive counterparts. In addition, dyslipidemia has also been 
found to be associated with IR, obesity and the Mets (26, 79). 
The name Insulin Resistance Syndrome (IRS) was first used in 1992 in a 
prospective analysis examining the association of hyperinsulinemia (used as 
proxy for IR) and incidence of HTN, T2D, and dyslipidemia over an eight year 
follow-up in the San Antonio Heart Study (88): The San Antonio Heart Study was 
a population-based study conducted in San Antonio, Texas. Mexican-American 
and non-Hispanic White men and nonpregnant women, aged 25-64 years, were 
randomly selected from all levels of socioeconomic status to examine the effects 
of the clustering of conditions described above on CVD incidence. This 
prospective analysis illustrated that hyperinsulinemia at baseline significantly 
increased the relative-risk of T2D five-fold, hypertriglyceridemia three-fold, HTN 
. two-fold and the presence of low HDL-C by 60%. Zavaroni et al. (231) found 
similar results in a prospective study when testing the hypothesis that 
hyperinsulinemia was positively associated with glucose intolerance, 
dyslipidemia, elevated uric acid concentrations, and HTN. Interestingly, in both of 
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the above studies these changes were independent of level of adiposity 
(obesity). 
Visceral obesity, IR, and dyslipidemia were assigned the name 
"plurimetabolic syndrome" by Despres (49) when examining how aerobic 
exercise influenced this trio of cardiovascular risk factors. In the Bruneck Study, 
which examined the prevalence of IR in metabolic disorders, the coexistence of 
IGT or T2D, dyslipidemia, hyperuricemia, and HTN were also designated the 
"plurimetabolic syndrome" (30). Given the metabolic nature of the syndrome, the 
name "metabolic syndrome" as proposed by Haller (91) has been rcognized as 
the most appropriate label by the clinical and research communities. 
Different medical society definitions of the metabolic syndrome 
In establishing an official diagnosis for the Mets, the American 
Association of Clinical Endocrinologists (AACE) championed the creation of the 
International Classification of Disease-9th revision ( ICD-9) Code 277.7 for the 
Mets (65). Currently, · there are currently five .working medical society definitions 
proposed for the diagnosis of the Mets. Table 1 summarizes the various 
definitions published by the following medical societies: .1) World Health 
Organization (WHO) (223), 2) European Group for the study of Insulin 
Resistance (EGIR) ( 14), 3) American Heart Association (AHA) and the National 
Heart, Lung and Blood Institute (NHLBI) definition (85) which refers to the 
updated National Cholesterol Education Program (NCEP) (2001) definition, 4) 
the American College of Endocrinology (ACE) and American Association of 
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Clinical Endocrinologists (AACE) consensus definition for epidemiological 
research (65), and 5) the International Diabetes Federation (IDF) (103). 
AHAINHLBI (updated NCEP) 
The majority of the recent research focusing on the metabolic syndrome 
involved the use of the NCEP definition because of its clinical utility (See Table 
1 ). The NCEP definition requires that three of the following five criteria be present 
for a diagnosis of the metabolic syndrome: impaired fasting glucose (IFG) 
represented by a fasting blood sugar � 110 milligrams per deciliter (mg/dl), 
including type 2 diabetes (T2D); HDL-C < 40 mg/dl in men and < 50 mg/dl in 
women; triglycerides � 150 mg/dl; an augmented waist circumference 0/VC) of > 
102 centimeters (cm) in men and > 88 cm in women, or a blood pressure value of _ 
> 130/BS millimeters of mercury (mmHg). The NCEP definition is -unique to the 
other metabolic syndrome definitions in the respect that it precludes specific 
inclusion criteria of any one condition (e.g. I FG) in order for metabolic syndrome 
to be d iagnosed. The most recent definition put forth by the AHA and NHLBI (85) 
mirrors the NCEP definition with the following modifications: medication use for 
those with dyslipidemia, HTN, and I FG maintains the diagnosis, and the. cut-off 
point for IFG was lowered from 110 mg/dl to 100 mg/dl to reflect the recent 
changes put forth by the American Diabetes Association (ADA) for IFG (2). 
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The WHO metabolic syndrome definition includes at least one of the 
following requisite conditions: impaired glucose tolerance (IGT) following an oral ·· 
glucose tolerance test (OGTT); tFG (� 110 mg/dl), including T2D; or insulin 
levels in the top quartile of the population; plus 2 of the following: HDL-C < 35 
mg/dL in men or 39 mg/dL in women or elevated triglycerides (� 150 mg/dL), a 
waist to hip (W:H) ratio >0.9 for men or >0.85 for women, or body mass index 
(BMI) > 30 kilograms per meters squared (kg/m2 ) in men or women, BP � 140/90 
mm/Hg, or microalbuminuria represented by a albumin creatinine ratio � 30 
milligrams per gram (mg/g). 
The EGIR definition requires insulin in the upper quartile of the 
background population, plus any 2 of the following:· HDL-C < 1.0 millimole per 
· liter (mmol/L) or 40 mg/dL or treatment for dyslipidemia, triglycerides > 2.0 
mmol/L (180 mg/dL) or treatment for dyslipidemia, WC of � 94 cm for men and � 
80 cm for women, blood pressure � 140/90 mmHg or treatment for HTN, or IGT 
following a oral glucose tolerance test (OGTT) or IFG (?: 11 O mg/dl) ,  but not 
diabetes. 
The IDF definition requires an augmented WC in Europeans and 
Americans of � 94 cm for men and � 80 cm for women. However, the IDF 
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recommends WC cut-off points that are population and/or ethnic specific with 
values of � 90 cm and � 80 cm in South Asian and Chinese men and women, 
respectively, and values of � 85 cm and � 90 cm in Japanese nien and women, 
respectively (234). In. addition to a requisite for an augmented WC, 2 of the 
following conditions must be present for metabolic syndrome diagnosis: IFG 
represented by a fasting blood sugar � 100 mg/dl, including T2D; HDL-C < 40 
mg/dl in men and < 50 mg/dl in women or treatment for lipid abnormality; 
triglycerides � 150 mg/dl or treatment for lipid abnormality; or a blood pressure 
value of � 130/85 mmHg or treatment for HTN. 
ACE/AACE 
The ACE/AACE definition requires one of the following: an individual to be 
classified as high risk (See Table 1); BMI >25 kg/m2 or WC of >102cm in men or 
>88cm in women, plus > 2 of the following: IFG (� 110 mg/dl ) or IGT following a 
OGTT, but not diabetes; HDL-C < 40 mg/dl in men or < 50 mg/dl in women; 
elevated triglycerides (> 150 mg/dl); or a BP > 130/85 mm/Hg. 
Metabolic syndrome prevalence has been shown to vary depending on 
which medical society definition is adopted (75, 76). Several prevalence studies 
have compared multiple definitions (15, 46, 51, 130, 215), however, since there 
is no consensus among definitions and various working definitions are continuing 
to be employed in both clinical and epidemiological research, comparisons 
between studies continues to be a difficult task. The following section will 
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examine the current international and national prevalence estimates of the 
metabolic syndrome. 
Current prevalence estimates 
It is estimated that close to one billion people worldwide have the 
metabolic syndrome (64) . Global prevalence estimates of the metabolic 
syndrome vary considerably, depending on the population under study, definition 
applied, and study design utilized. The increasing number of people with the 
metabolic syndrome can be attributed in part to population growth, aging, excess 
caloric intake, and an inactive lifestyle (169). There have been numerous 
population based cross-sectional (7, 9, 12, 34, 58, 72, 73, 75-77, 86, 112, 123, 
139, 147, 157, 165, 167, 171, 203, 215) and cohort studies (145, 148) done that 
have estimated the metabolic syndrome prevalence. Among these studies, only 
12 have estimated the prevalence of the metabolic syndrome utilizing a nationally 
representative sample of adults (7, 9, 31, 33, 34, 73, 75-77, 86, 119, 161). The . 
following section will examine all the cited-prevalence studies that utilized a 
national representative sample, starting with the international studies, followed by 
the national (U.S. )  studies. 
International prevalence estimates 
In the Australian, Obesity, and Lifestyle Study (AusDiab) , which was a 
national population-based cross-sectional survey of the prevalence of diabetes 
and other cardiovascular risk factors in people aged � 25 years, the prevalence 
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estimates of the metabolic syndrome were reported utilizing three different 
definitions (33). Overall prevalence estimates from the AusDiab were reported to 
be 15.9% for the EGIR definition, 18 .3% for the NCEP definition, and 20.9% for 
the WHO definition. The same research group, utilizing the WHO and NCEP 
definitions, reported the prevalence estimates of the metabolic syndrome 
originating from a national sample of Mauritians (34 ). Mauritians are comprised of 
a mixture of Indians, Creoles, Chinese, Europeans, Zarabes, Kaffirs and 
Malabars living on a sub-continent off the coast of India. The metabolic syndrome 
prevalence estimates in this highly heterogeneous group were found to be 19.1 % 
(WHO) and 13.8% (NCEP). 
The estimated prevalence of the metabolic syndrome in Greece was 
reported in a cross-sectional analysis of a representative sample of Greek adults 
participating in the Metabolic Syndrome-Greece Multicentre Study (8). The 
estimated prevalence of the metabolic syndrome originating from this national 
sample was 23.6% utilizing the NCEP definition. In cross-sectional survey of a 
national representative sample of White, Black, Amerindian, and Mixed Hispanics 
� 20 years of age in Venezuela, the prevalence of the metabolic syndrome and 
its associated risk factors was identified (73). The estimated prevalence of the 
metabolic syndrome was reported to be 31.2% utilizing the NCEP definition. This 
was the first national study examining metabolic syndrome prevalence in South 
America. 
The International Colfaborative Study of Cardiovascular Disease in ASIA 
(I nterASIA) was a cross-sectional study of CVD risk factors in a national sample 
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of Chinese adults (86). Utilizing the NCEP criteria, the estimated prevalence 
among Chinese adults was 13. 7%. However, the NCEP criteria may not be 
appropriate for Asian populations (93 , 224). Subsequently, adjustments for the 
HDL-C cut-off point being � 1.0 mmol/L for both men and women and WC cut-off . 
points being lowered to > 90 cm for men and > 80 cm for women increased the 
metabolic syndrome prevalence estimate in Chinese adults to15. 1 %� 
The estimated prevalence of the metabolic syndrome in Japan was 
recently reported in a national survey of adults aged 20-79 years (7). This study 
utilized the new definition released from the Japanese Committee for the 
Diagnostic Criteria of the metabolic syndrome. The Japanese metabolic 
syndrome definition requires the presence of abdominal obesity defined as a WC 
of � 85 cm in men and .:: 90 cm in women, plus 2 of the following: triglycerides � 
150 mg/dL and/or HDL-C < 40 mg/dL or treatment for dyslipidemia; blood 
pressure .:: 130/85 mm/Hg or treatment for HTN; and IFG .:: 110 mg/dL or 
treatment for diabetes. Participants taking medication for dyslipidemia were 
excluded in this study °because data allowing differentiation of treatment for 
hypercholesterolemia or hypertriglyceridemia could not be obtained. In Japanese 
adults, the national metabolic syndrome prevalence was estimated to be 7.8%. 
In the Korean National Health and Nutrition Examination Survey 
(KHANES), the prevalence of the metabolic syndrome was estimated in over 
4,000 Korean adults (119). This study was conducted to compare prevalence 
estimates of the metabolic syndrome as defined by the I OF and NCEP, and the 
obesity criteria put forth by the WHO and the Korean Society for the Study of 
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Obesity (KSSO) (136) . The WHO WC cut-points in Korean adults are � 90 cm in 
men and � 80 cm in women. The WC cut-points according to the KSSO are � 90 
cm in men and � 85 cm in women. The WHO recommendation lowers WC cut­
point in men by 5 cm and utilizes the same lDF cut-points in women. The KSSO 
also lowers WC recommendations to � 90 cm in men; however, the women cut­
point is raised 5 cm above the IDF criteria. 
The age-adjusted prevalence of the metabolic syndrome within the 
KHAN ES was estimated to be 23.8% and 17 .5% utilizing the modified 1DF 
definition and WHO obesity criteria, and modified IDF definition and KSSO 
obesity criteria, respectively (119). The age-adjusted prevalence estimates for 
the NCEP modified by the WHO definition and the NCEP modified by KSSO 
definition were 26.7% and 23.7%, respectively. The prevalence of the metabolic 
syndrome as defined by NCEP, modified by the WHO, was the highest (26.7%; 
95% Cl, 26.0-27.4), while the prevalence of the metabolic syndrome defined by 
the IDF modified by the KSSO was the lowest 17.5%, 95% Cl, 16.9-18. 1). This 
study clearly illustrated how metabolic syndrome definition (and definition 
modification) can impact prevalence estimates. 
In a study examining PA and the metabolic syndrome in Canada, the ·age­
adjusted national prevalence of the metabolic syndrome was also estimated (31) 
utilizing a modified NCEP definition in the Canadian Heart Health Survey 
(CHHS). The CHHS was a series of national representative cross-sectional 
surveys of CVD risk factors in Canadians aged 18-74 years, conducted between 
· 1986 and 1992. Data on glucose and WC values were only obtained on half of 
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the participants, therefore self-reported physician diagnosed T2D was substituted 
for glucose, and BMI was used in place of WC. The age-adjusted estimated 
metabolic syndrome prevalence in Canadian adults surveyed between 1 986 and 
1992 was 1 4.4%. 
Prevalence estimates in the United States 
In the U.S., Ford et al. (77) first reported the estimated prevalence of the 
metabolic syndrome in a national representative sample of adults, aged � 20 
years, utilizing data from the 1988-1994 Third National Health and Nutrition 
Examination Survey (NHANES I l l) (41). NHANES I l l  was a cross-sectional health 
survey of a national representative sample of noninstitutionalized U.S. adults. 
The estimated age-adjusted prevalence of the metabolic syndrome utilizing the 
NCEP criteria was found to be 23 .7%. This was the first report of metabolic 
syndrome prevalence estimates in the US. In a follow-up study utilizing the same 
NHANES I ll data, Ford et al. (76) reported the prevalence of the metabolic 
syndrome comparing two different medical society definitions, the WHO definition 
and NCEP definition. The estimated age-adjusted prevalence of the metabolic 
syndrome utilizing the WHO definition was 25.1 % and the NCEP definition w·as 
23.9%. These two prevalence estimates were not significantly different. Ford et 
al. reported that the reason the prevalence estimates utilizing the same data set 
and NCEP definition varied slightly from the first prevalence estimates (77) was 
due to differences in the analytical sample sizes. 
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The most recent prevalence estimate of the metabolic syndrome in the 
U.S. were reported by Ford et al. (75) utilizing the newly released IDF definition 
(103). This study also used 1999-2002 NHANES (39). In addition to estimating 
metabolic syndrome prevalence using IDF definition, this study also ex.amine� 
prevalence using the NCEP definition. The age-adjusted national prevalence 
· estimates for the metabolic syndrome were found to be -39.1 % (IDF) and 34.6% 
(NCEP). These two prevalence estimates were found to be significantly different, . 
illustrating for the first time in a national sample of U.S. adults, how the metabolic 
syndrome definition applied can impact prevalence. 
A cross-sectional examination of the last two releases of the NHANES 
(1988-1994 and 1999-2002) data illustrates a 10% increase in the prevalence of 
the metabolic syndrome in US adults, depending on the definition applied (75, 
77). With the metabolic syndrome becoming more common in Westernized 
societies (64 ), the prevalence and incidence are anticipated to increase in line 
with the prevalence and incidence of obesity (152) and T2D (225). 
Physical activity and defining metabolic syndrome criteria 
Insulin resistance and physical activity 
PA and its positive effects on blood sugar control were first observed in 
the early part of the twentieth century (170). Regular physical activity has been 
shown to improve rates of glucose uptake in a similar fashion to insulin. Muscle 
fiber contraction increases the number and activity of glucose transport proteins i : 
GLUT-4, in skeletal muscle (83, 97). Thus, contracting skeletal muscle has 
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'insulin like effects ' on glucose uptake. Furthermore, contracting skeletal muscle 
does not require_ the presence of insulin in order to take up glucose. 
Reaven (172, 173) and others (45, 69) have clearly illustrated IR to be the 
core component of the metabolic syndrome. I t  has been found to be present in 
approximately 25% of western society (22, 45, 173). The etiology of I R  involves 
diminishing beta-cell function over time, and has been estimated to result in IGT 
and eventually frank T2D approximately 30%-40% of the time (218). Saltin et al. 
(186) demonstrated that a low aerobic capacity, expressed per kilogram of body 
weight, may manifest itself as an early component of the metabolic syndrome, 
particularly in individuals likely to go on to develop T2D. Furthermore, histological 
evidence has demonstrated that IR/hyperinsulinemic individuals have attenuated 
mitochondrial and capillary density in skeletal muscle , accompanied by a 
decreased type I versus type I I  fiber ratio (146). Therefore, genetic abnormalities 
in skeletal muscle may limit aerobic capacity, thus resulting in lower levels of .. . 
physical activity. 
Several cross-sectional studies have illustrated that individuals- who 
reported performing large amounts of aerobic PA on a consistent basis .present 
with lower serum insulin levels, both in the fasting and postprandial state (21, 63, 
178). Similar effects have been reported in older men and women (181, 182, 
190). Therefore, regular PA also appears to insulate individuals from the 
deleterious effects of glucose intolerance associated with the normal aging 
process. When examining insulin sensitivity and glucose uptake in PA 
intervention studies, acute bouts of PA (28) and lifestyle changes including 
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regular aerobic (101, 199, 200) and strength training activities (114, 149) have 
been shown to enhance insulin sensitivity, thus improving glucose control in 
subjects with varying levels of glycemia and BMI (142, 210). 
Hypertension and physical activity 
Essential (i.e., no known cause) HTN is a heterogeneous condition which 
has been shown to be associated with hyperinsulinemia (45, 68, 70, 71, 173, 
176). Hypertension has been studied more than any other condition defining the 
metabolic syndrome (43, 67, 89, 94, 104, 174, 191, 195, 197, 232). As reported 
by the Seventh Joirit National Committee on Prevention, Detection, Evaluation, 
and Treatment of High Blood Pressure (JNC VI I )  (43), approximately 25% of the 
US population is estimated to be hypertensive as classified by a systolic blood 
pressure (SBP) � 140 mmHg, a diastolic blood pressure (DBP) � 90 mmHg or 
taking anti-hypertensive medication. It has also been estimated that another 22% 
of the US population falls into the prehypertension category which is classified as 
a SBP between 120-139 mmHg or a DBP that falls between 80-89 mmHg. This 
prehypertension category carries with it a recommendation for lifestyle changes 
before introducing pharmacological treatment (43). These changes, which are 
also recommended for individuals with diagnosed HTN, include increasing the 
amount of regular PA and making healthy dietary changes (e.g., sodium 
restriction) leading to weight loss to help prevent the development of HTN. 
Regular PA has been shown to be associated with more favorable blood 
pressure (BP) values (18, 89). Tanaka et al. (201) found a decrease in both 
34 
sitting and supine SBP in 18 previously sedentary subjects with stage 1 and 
stage 2 HTN following 10 weeks of supervised swimming. Dengel et al. (47) 
reported decreases in both SBP and DBP following nine months of aerobic PA, 
three days per week a·nd gradually reaching 40 minutes per session. Similar 
findings were reported by Fagard (67) demonstrating a decrease in BP in both 
normotensive and hypertensive individuals, however the effect was more 
pronounced in the hypertensive group. 
Ishikawa et al. (107) reported a significant drop in blood pressure in both 
sedentary men and women age 30-69 years with stage 1 and 2 hypertension 
following an eight week PA program. In addition, this study demonstrated no 
differences in the efficacy of PA between genders; however, the older 
hypertensive subjects experienced less of a reduction in BP following the 
exercise program than their younger counterparts. Similar reductions in both SBP 
and DBP were reported by Swartz et al. (200) following an eight week walking 
program of 10,000 steps per day in overweight women. Overall, regular PA has 
been shown to decrease SBP and DBP in nearly 75% of people with HTN (89). 
Dyslipidemia and physical activity 
Atherogenic dyslipidemia commonly associated with the metabolic 
syndrome is represented by elevated triglycerides and decreased- levels of HDL- · 
C, particularly HDL2-C (25, 26, 175) which is associated with cardioprotection. 
The Diabetes Prevention Program (OPP) Research group (Rockville, MD) (50) 
reported that individuals with IGT, compared with individuals who go on to 
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develop T2D, were very similar. Individuals with either IGT or T2D showed 
minimal differences in BP; triglycerides; HDL-C or non-HDL-C; or low-density 
lipoprotein cholesterol (LDL-C); implying that cardiovascular risk factor profile for . 
T2D differs very little from that of IGT. This suggests that the IR phenotype may 
be primarily responsible for the dyslipidemia characteristic of hyperglycemia. 
Regular PA has been shown to demonstrate favorable effects on lipid 
profiles (6 1, 226 , 227). PA can augment the capacity of muscle tissue to take up 
and oxidize non-esterified fatty acids (25, 61) and increase the activity of 
lipoprotein lipase (LPL) in muscle (164). Individuals who engage in regular PA, 
compared to those who are physically inactive, have been found to have higher 
levels of HDL-C and HDL2-C, in addition to lower levels of triglycerides and LDL­
C. In contrast, limited evidence exists demonstrating that individuals who are 
physically active possess lower levels of total cholesterol (TC) and LDL-C (121, 
122, 133). Hence, some lipids and lipoproteins are _more favorably impacted by 
exercise and PA than others (59). 
There have been several studies examining the relationship between 
volume of PA and changes in blood lipid levels (52, 53, 120, 1 24, 1 33 ,  226, 227). 
Drygas et aL (52) found HDL-C to be· approximately 6 mg/dL greater in men who 
were physically active when compared to the least active group. In a similar 
study design, Kokkinos et al. - ( 120) reported an inverse association between 
miles run per week and TG levels, and a positive association between HDL-C 
and miles run per week in a group of middle-aged men. In women, similar results 
have been reported. Durstine et al. (62) reported HDL-C levels were greater in 
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female recreational runners and even greater in female elite runners versus their 
sedentary counterparts, thus demonstrating a favorable positive association. The 
positive association between HDL-C levels and running volume were similar for 
men and women, however TG and TC:HDL-C ratios remained intact (226). 
The frequency of favorable changes reported in HDL-C and TG levels 
following regular PA suggests that these lipid values are more responsive to 
regular PA than TC and LDL-C (60). Although regular PA results in minimal 
changes in TC and LDL-C in the absence of weight loss (198), the 
concentrations of LDL-C, particularly small dense LDL-C has been shown to 
decrease, while LDL-C particle size is augmented, resulting in a less atherogenic 
environment (124). Regular PA has also been shown to have favorable effects 
on the atherogenic dyslipidemia associated with the metabolic syndrome (27 , 50, 
60). In addition, prospective studies (124, 204, 226, 227) have confirmed · 
additional improvements in these lipid values with increases in the volume of PA 
performed, thus suggesting a potential dose-response association. 
Obesity and physical activity 
In a recent 2006 study, Ogden et al. (159) reports the current prevalence 
of overweight and obesity in the U .S. adult population to be 66.5%. The 
metabolic syndrome has been shown to be linked to increased levels of 
abdominal or central adiposity (19, 20, 45, 48, 75, 77, 116,  160, 161 ,  179). Upper · 
body obesity, formerly known as android obesity (211) carries the highest level of 
cardiovascular risk and is ubiquitous among the defining criteria in all the working 
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definitions of the metabolic syndrome (14, 65, 85, 103, 155, 223). Regional fat 
distribution studies performed with computed topography (CT) scanning and dual 
energy x-ray absorptiometry (DEXA) have demonstrated that higher levels of 
visceral adiposity are related to greater degrees of I R  and HTN (44, 81), thus 
creating a more atherogenic environment. However, these findings are not 
consistent across racial groups (13). 
High levels of physical inactivity have been reported to be the seminal 
etiology in the rapid rise in obesity rates (127, 168). Regular bouts of PA have 
been shown to improve percent body fat and body fat distribution. In a cross­
sectional study, Troisi et al. (208) found both BMI and waist to hip ratio to be 
inversely associated with regular PA. In NHANES I ll, women who met or 
exceeded the Centers for Disease Control and Prevention and the American 
College of Sports Medicine (CDC/ACSM) public health recommendation for PA 
(162) were found to have lower BMI, percent body fat, and waist to hip ratios 
compared to those not meeting the recommendation or reporting being physically 
inactive (96). 
Folsom et al. (74) reported in a study of 25-74 year old men and women, 
that adults expending 2,000 kilocalories (kcals) per week in leisure time physical 
activity (L TPA) had significantly lower BMI values. Similar results were seen in 
the Bogalusa Heart Study (87). This study examined reported levels of leisure­
time PA (L TPA) and physical inactivity and found L TPA to be inversely related 
with BMI and WC. I n- contrast, a cross-ove.r design study consisting of 22 healthy, 
slightly overweight, sedentary men resulted in little change in body weight, 
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percent body fat, BMI or overall cardiovascular risk profile following 1 2  weeks 
moderate to vigorous PA (138). One explanation for this may be low levels of 
non-L TPA (domestic activities), which have been shown to reduce CVD risk at 
higher levels (221 ). 
Findings from several prospective studies suggest that overweight and 
obesity may be more due to low levels of energy expenditure and not 
hyperphagia (118, 168, 228). Prospective studies however, have shown 
moderate amounts of PA result in small to moderate weight loss when compared 
to hypocaloric diets alone (95, 126, 137, 163, 188, 222). Nonetheless, several 
recent prospective studies have demonstrated that combining regular PA with a 
weight loss program in individuals at increased risk for developing the metabolic 
syndrome can have favorable effects on the metabolic profile, thus reducing the 
risk of the metabolic syndrome (50, 142, 2 10, 220). Therefore, adding PA to any 
prescribed weight loss program would be prudent. Including regular PA as an 
adjunct to a weight loss program has also been shown to result in a 
disproportionate amount of visceral fat loss ( 1 89). Furthermore, PA has been 
shown to increase as a function of body weight (209), therefore, regular weight 
maintenance is recommended for prevention of the metabolic syndrome (140). 
Similar benefits from performing regular PA have also been observed in 
older adults. Favorable effects on body weight, body composition, lean body 
mass (LBM), and intra-abdominal adipose tissue have been observed in male 
and female master athletes (1 66, 183, 21 4) compared to sedentary age-matched 
controls. With losses of one kilogram of muscle per year after .the fifth decade of 
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life, PA programs that include resistance training (RT) can help attenuate this 
process while preserving function (156). 
Physical activity and the metabolic syndrome 
The health benefits of regular PA are well recognized (162). A search of 
the peer-reviewed literature on the association between PA and the metabolic 
syndrome identified 25 studies, 19 cross-sectional studies (31, 32, 37, 54, 56, 78, 
80, 87, 90, 105, 114, 132, 143, 144, 150, 161, 187, 217, 233) and six prospective 
studies (36, 66, 113, 117, 129, 131 ). Central to the research and literature 
examining the association of PA and the metabolic syndrome is the issue of PA 
volume. Frequency, intensity, and duration of PA are the components used to 
precisely measure PA volume. 
The following section will discuss the 25 studies identified in the literature 
examining the association between PA and the metabolic syndrome. Both the 
cross-sectional and prospective studies identified in the literature will be _ 
presented by level of precision in which PA is measured , starting with least 
precise and leading to the most sensitive measures of PA. Predominantly, these 
studies focused on L TPA and not physical activities from the other PA domains 
(i.e . ,  domestic, transportation.) 
Muscular strength and the metabolic syndrome 
In a study examining ·the association of musc�lar strength with the risk of 
having the metabolic syndrome (155) , Jurca et al. (114) grouped 8,570 men aged 
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20-75 years enrolled in the Aerobic Center Longitudinal Study (ACLS) into 
s�rength quartiles based on one-repetition maximal (1-RM) efforts on variable 
resistance equipment. The 1-RM tests performed to calculate a strength index 
were the supine bench press, seated leg-press, and leg-extension. Quartile 1 
represented the lowest strength index and served as the referent group. Men in 
quartiles 2, 3, and 4 were found to be 38% (OR 0.62 ; 95% Cl, 0.53-0.72)� 57% 
(OR 0.43; 95% Cl, 0.37-0.52), and 67% (OR 0.33; 95% Cl , 0.28-0.40) less likely 
to have the metabolic syndrome, respectively after adjusting for age and 
smoking. However, after adding maximal treadmill time (which is used as a 
surrogate measure of cardiovascular fitness in the ACLS) to the model, this 
association was slightly attenuated, leaving only men in the top two quartiles for 
strength protected from the metabolic syndrome. This finding is not unusual 
given the positive impact cardiorespiratory fitness has on metabolic risk ( 1 ,  24, 
105, 132, 135). 
In a follow-up to a cross-sectional study examining the association 
between muscular strength and the metabolic syndrome (11 4), thasame 
research group examined the association of muscular strength with incidence of 
metabolic syndrome in a longitudinal study (113). Subjects were 3,233 men aged 
20-80 years enrolled in the ACLS at the Cooper Clinic in Dallas, Texas from 
1980-1989.These men were free from CV disease(s) at baseline. Assessment of 
muscular strength and defined strength quartiles have been described previously 
(114 ). Quartile 1 defined the low strength category and served as the referent 
group. 
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The mean follow-up in this study was 6.7 years (range 0.1-22.0 years). A 
total of 480 men developed the metabolic syndrome during this time. Men in 
quartile 3 and quartile 4 were found to be 23% and 46%. less likely to develop the 
metabolic syndrome compared to men in quartile 1 when controlling for age and 
examination date. However, following the addition of smoking status, alcohol 
intake, number of metabolic syndrome risk factors at baseline, family history of 
diabetes, HTN, and early onset coronary artery disease to the model, this 
association was attenuated. Following these adjustments, only men in strength 
quartile 4 remained at a decreased risk for developing the metabolic syndrome 
OR 0,.76 (95% Cl , 0.57-0.99). Others have also illustrated the benefits of 
resistance training and increases in muscular strength on metabolic risk (38, 55, 
92, 99, 102, 206). Muscular fitness appears to add another level of protection 
against the metabolic syndrome in men (114) and may help with daily and long­
term glycemic control. 
Total physical activity time 
In the Bogalusa Heart Study (87), self-reported levels of PA in hours and 
the risk of having the metabolic syndrome as identified by Reaven (173) was 
examined. Two questions assessing the level of PA were asked as part of a 
detailed health questionnaire. Anyone who replied "do not work" for the work 
related activity question (question 1) was not included in the analysis. Question 2 
asked about PA outside of work. Both questions provided responses ranging 
. from 1 (inactive to 5 (very active). Questions regarding frequency, intensity, time, 
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and type were not part of the questionnaire. Total L TPA status was divided into 
quintiles ( 1  = inactive; 2=some activity; 3=moderate activity; 4=moderate-vigorous 
activity; and 5=vigorous activity) to assess the possible inverse association of 
having the metabolic syndrome. Individuals who reported being moderately to 
vigorously active were 44% to 69% less likely to have the metabolic syndrome 
compared to those who reported being inactive; OR 0.56 (95% Cl, 0.36-0.87) for 
moderate, (OR 0.3 1;  95% Cl, 0. 16-0.58) for moderate-vigorous, and OR (0.41; 
95% Cl, 0.24-0.71) for vigorous. A inverse association was noted between the 3rd 
and 4th quintile, however no further reduction in risk was noted specific to the 5th 
quintile. 
The association between performing PA and having the metabolic 
syndrome was examined in the Coronary Artery Risk in Young Adults (CARDIA) 
study (36). The study population was made up of over 4,000 black and white 
males and females without the metabolic syndrome. Incidence of metabolic 
syndrome was observed at baseline, 7, 10, and 15 years. Regular leisure-time 
and occupational. physical activities were assessed by the validated Minnesota 
Heart Health Program questionnaire (109). Age-adjusted rate of metabolic 
syndrome were reported per 1,000 person years. Subjects who reported PA 
levels above the study population mean at all four follow-up examinations were 
classified as being regularly active; those with inconsistent measures over time 
were considered moderately active. 
Over a mean of 13.6 years of follow-up, the metabolic syndrome was 
diagnosed in 575 participants (36). The age-adjusted metabolic syndrome rate 
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was 1 O per 1,000 person years. This was similar in both genders; however, black 
women had the highest overall incidence. Following adjustments for age, race, 
gender, weight gain, and PA over time, participants who remained regularly 
active were found to be 51 % (OR 0.49; 95% Cl, 0.34-.070) less likely to have the 
metabolic syndrome compared to their sedentary counterparts. The addition of 
education, baseline BMI ,  baseline PA, smoking status, drinking status, and 
dietary covariates to the model attenuated this association slightly, however it 
remained significant (OR 0.65; 95% Cl, 0.76-0.98). 
In a NHANES I ll (41) study examining the association of LTPA and the 
metabolic syndrome, as defined by NCEP, in U.S. adults. DuBose et al. (54) 
defined L TPA as a three level categorical variable. PA was assessed by 
questionnaire, however, duration of each bout of L TPA was not assessed in 
NHANES 1 1 1 , and therefore, -the quantification of LTPA energy expenditure was 
not possible. L TPA was categorized into 3 levels: inactive, irregularly active, and 
regularly active in order to assess the possible dose-response characteristics of 
LTPA. Moderate LTPA was defined as activity ranging from 3-6 METs, and 
vigorous activity was defined as > 6 METs. Each activity was then assigned an · 
intensity level· (3). Frequency of L TPA was recorded as days per week (d/wk) and 
dividing the number days per month of L TPA by 4.3 weeks. Those completing � 
5 d/wk of moderate LTPA and/or � 3 d/wk of vigorous LTPA were considered 
regularly active, those who reported some LTPA, however not � 5 d/wk of 
moderate or � 3 d/wk vigorous, were considered irregularly active. Participants 
who reported no LTPA over -the last 30 days were considered inactive. Irregularly 
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active and inactive men were found to be 52% (OR 1 .60; 95% Cl, 1.11-2.31) and 
60% (OR 1.52; 95% Cl, 1.18-1.98) more likely to have the metabolic syndrome 
compared to regularly active men after adjustment for age, race, gender, and 
education. These findings illustrate a protective association for participating in 
regular L TPA in men. In contrast, pt,y§ical inactivity was not found to be 
associated with the risk of having the metabolic syndrome in women. These 
findings were consistent with previous studies examining the level of L TPA and 
risk of having the metabolic syndrome in women (1 05, 131, 161). 
In the first two years of most recent NHANES (1999-2000) (40), a 
nationally representative sample of the noninstitutionalized U.S. population, the 
association between sedentary behavior, PA, and the metabolic · syndrome ( 1 55) 
was examined (78). 1,626 participants, � 20 years of age,. who reported for a 
morning medical examination were included in the study. During this 
examination, subjects were asked to report the frequency and duration that they . 
spent performing 43 different leisure-time physical activities and any type of 
domestic physical activities of moderate or vigorous ·intensities (40), however, 
available data on absolute intensities for each activity (METs) were not utilized in 
this study. The total PA time in minutes perweek (min/wk) was calculated by 
summing the weekly minutes of participation for each activity . A three level 
categorical variable was then created: 0 min/wk; < 150 min/wk; and � 1 50 
min/wk. Time spent watching TV or playing video games was assessed and a 
three level categorical variable was developed for part of the analysis: � 1 hour 
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per day (hr/d), 2 to 3 hr/d, and � 4 hr/d; and a five level categorical variable for 
another part of the analysis: < 1 hr/d, 2 hr/d, 3 hr/d, and � 4 hr/d. 
. In this study, men and women who were physically inactive were found to 
be 63% (OR 1.65; 95% Cl, 1 .01-2.65) more likely to have the metabolic 
syndrome after controlling for age, than those reporting �-150 min/wk of PA. 
However, after adding gender, ethnicity, education, smoking status, - and alcohol 
intake to the model this association was attenuated and became non-significant 
(OR 1.45; 95% Cl, 0.86-2.44). When stratified by gender, women were over twice 
as likely to have the metabolic syndrome when reporting no PA compared to 
women reporting � 150 min/wk (OR 2.35; 95% Cl , 1.19-4.63). Physical inactivity 
was not associated with the metabolic syndrome in men following stratification. · 
Participants reporting watching TV and/or playing video games � 4 hr/d were 
found to be twice as likely to have the metabolic syndrome when compared · to 
· those reporting these activities for < 1 hr/d. Following stratification by gender, 
women were almost three times as likely to have the metabolic syndrome if they 
reported watching TV or playing video games � 4 hr/d when compared to women 
reporting < 1 hr/d of these activities. Regardless of their level of TV viewing or 
video game playing,· men were not found to be at an increased risk for the . .  
metabolic syndrome. 
The 1999-2000 AusDiab Study collected data from a national 
representative sample of over 11,000 adults in Australia (57). From this 
population, 7,821 adults > 35 years of age who had complete data on metabolic 
syndrome criteria, television (TV) viewing time, and PA time were enrolled in a 
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study to examine the association of time spent watching TV and hours per week 
(h/wk) engaging in moderate· or vigorous PA with the likel ihood of having the 
-- metabolic syndrome (56, 223). Subjects, using a previously val idated tool (1 84), 
reported total TV viewing time or time spent playing video games over the 
previous seven days. A three level categorical was created for TV viewing: 0-7 
hours per wk (hr/wk), 7. 1-14 hr/wk, and > 14 hr/wk. The validated Active 
Australia Survey Questionnaire (10) was utilized to collect data on subjects 
frequency and.duration of PA over the previous seven days. This included 
activities like walking for exercise or transportation, 'other' moderate activities 
and vigorous activity. The total PA time was summed by adding time spent 
walking and performing 'other' moderate activities and then adding double the 
time spent performing vigorous PA. The 'Active Austral ia' method takes into 
account the higher physical activity energy _expenditure (PAEE) per unit of time 
associated with higher intensity PA (10). 
In this study, men were found to be 64% more likely to have the metabolic 
syndrome and women were found to be over two times as likely to have the 
metabolic syndrome if they reported watching TV or playing video games > 1 4  
hr/wk. However, after controlling · for· age, education, family history of diabetes, 
smoking status, and dietary covariates, only women remained at risk. Men and 
women reporting participating in � 2.5 hr/wk of total PA were found to be 28% 
(OR 0.72 95% Cl, 0.58-0.90) and 47% (OR 0.53; 95% Cl, 0.38-0.74) less likely to 
have .the metabolic syndrome, respectively, after controll ing for-all confounders . 
. Furthermore, women were 38% (OR 0.62; 95% Cl, 0.41-0.95) less likely to have 
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the metabolic syndrome if they reported walking or 'other' moderate PA and 68% 
(OR 0.32; 95% Cl , 0. 13-0. 78) less likely to have the syndrome if they reported � 
60 min of vigorous PA per week. Men only received protection from total of � 2.5 
hr/wk of PA performed. One explanation for this may be women have been found 
to report PA more accurately than men (205). Also, limitations of the 
measurement tool, which excluded both domestic and occupational domains of 
PA must be considered. 
Physical activity energy expenditure (PAEE) 
Some investigators have utilized total PAEE when examining potential 
associations between PA and the metabolic syndrom·e. Determining the effects of 
PAEE on the risk of having the metabolic syndrome (223) is paramount i due to 
the fact that it may be_ easier to get people to make small changes in their total 
energy expenditure than trying to improve their fitness level (80). In a study 
analyzing ·the relationship between habitual energy expenditure, fitness and the 
metabolic syndrome, the physical activity level (PAL) was developed to measure 
PA (217). The PAL was derived from estimating total kcal energy expenditure 
using the HRFlex method (42) and basal metabolic rate (BMR) to examine the 
association with the metabolic syndrome as defined by Reaven (173). The 
oxygen consumption-heart rate (HR) relationship was assessed at rest (217). 
Subjects were asked to come into the laboratory and cycle on an ergometer at 0 
watts (YV), 37.5 W, 75 W, and 125 W. Data on HR and oxygen and carbon 
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dioxide subfractions were collected. Energy expenditure was designated in 
kilojoules per minute (kj/min) . 
Flex HR, which is the point used to differentiate between inactivity and 
exercise was calculated as a mean of the highest resting pulse and the lowest 
HR during exercise. Mean resting energy expenditure was calculated and basal 
metabolic rate was predicted (82). Cardiorespiratory fitness 0/02 max) was 
predicted as oxygen uptake at maximal HR determined from a regression line 
during the individual HR calibration. Heart rate monitors were worn for four days 
and PAL was derived from subtracting the average energy expenditure at rest, 
from total energy expenditure. This was expressed in units of fat free mass 
(FFM) . PAL was divided into quartiles with the lowest PAL defining the referent 
group. Utilizing multiple-logistic regression analysis, the overall association 
treating PAL quartile as a ranked categorical variable .for the metabolic syndrome 
was 0.64 (95% Cl 0.43-0.94) per quartile. The OR following adjustments for sex 
and BMI was 0.62 (95% Cl , 0.42-0.92) ; 
In a cross-sectional study of 874 healthy Caucasian participants from the 
Medical Research Council (MRC) Ely Study (216) , the association of habitual PA 
expressed as PAEE and the likelihood of having the metabolic syndrome was 
evaluated (80) . In addition, cardiorespiratory fitness levels were obtained to 
examine whether PA or fitness provided more protection from the metabolic 
syndrome. The HR Flex methodology for this study is described above (217) . 
Following adjustments for age, gender and V02 max, the association be.tween 
PAEE expressed in kj/kgFFM and the metabolic syndrome were three times 
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stronger than the associations for V02 max-pred , These data also illustrate that 
those below the mean level of fitness (V02 max-pred) are less likely to have the 
metabolic syndrome if they acquired an adeq·uate level of PAEE. With PAEE 
divided into quartiles, a clear inverse association was observed for increasing 
levels of PAEE and the likelihood of having the metabolic syndrome: Also, these 
data suggest that increasing levels of PAEE may be more effective in less fit 
individuals. 
Ekelund et al. (66), in the MRC Ely Study (217), examined whether PAEE 
and aerobic fitness (V02max) predicted the development of the metabolic 
syndrome (223) in a group of middle-aged healthy Caucasian men over a 5.6 
year time frame. PAEE was measured using the flex heart method described 
previously (80) and aerobic fitness (V02max) was predicted by extrapolation and 
expressed per unit of FFM (80). 
PAEE was divided into quartiles: < 44 kilojoule (- 10.5 kcal) per kg of FFM 
per day (kJ/kgFFM/d); 44-70 (- 10.5-17 kcal) kJ/kgFFM/d; 71-100 (-17-24 kcal) 
kJ/kgFFM/d; and > 100 (-24 kcal) kJ/kgFFM/d. The PAEE at baseline significantly 
predicted progression toward metabolic syndrome at 5.6 years. There was a 
significant difference found between the first and second quartile of the PAEE 
and the likelihood of having the metabolic syndrome. However, no additional 
decrease in risk was observed in other quartiles, thus suggesting a threshold 
effect for a PAEE of � 44 kJ/kQFFM/d or 10.5 kcals per every 2.2 pounds of FFM 
per day. This association was unchanged after adjusting for level of adiposity as -
measured by WC or percent body fat. This was the first population-based 
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prospective study that used a validated objective measure to examine the 
association between PAEE and the metabolic syndrome (80). 
The association between L TPA and the likelihood of having the metabolic 
syndrome was examined in the CHHS, which is a national representative sample 
of Canadian adults surveyed between 1986 and 1992 (31). Participants were 
classified as physically inactive or active in accordance with their levels of self­
reported L TPA. A participant was considered active if they reported performing at 
least 30 minutes of L TPA that induced sweating, once a week over the last 30 
days. If they did not meet these criteria, they were considered inactive. The 
information provided on intensity (sweating) was not enough to determine 
whether moderate or vigorous LTPA was performed. Men, but not women who 
reported at least 30 minutes of L TPA that induced sweating four times over the 
last month were found to be less likely (OR 0.45; 95% Cl , 0.29-0.69) to have the 
metabolic syndrome, however, women did not receive the same protection (OR · 
0.67; 95% Cl, 0.44-1.02). However, without information regarding L TPA intensity, 
LTPA volume was unable to be determined. Having information on intensity may · 
have helped elucidate why there was no protective association found between 
L TPA and the metabolic syndrome in women in this study. 
Metabolic equivalents (METs) of physical activity 
A more sensitive measure for expressing total volume ·of PA includes 
utilizing a measure of absolute intensity expressed in METs. METs are obtained 
by dividing the oxygen uptake in mL·kg·1 ·min·1 by 3.5 mL·kg·1 ·min·1 ( 100}. This 
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can also be expressed in MET·min ·wk-1 ; for example, an individual running 5 
times per week at an intensity level of 4 METs for 30 minutes would accumulate 
600 METmin·wk-1 of PA: 
(5 times/week) * (4 METs) * (30 minutes) =600 MET·min·wk·1 
Recently, physical activity epidemiology studies examining the metabolic 
syndrome and the role of PA (105, 129, 131, 144, 177) have been able to utilize 
a more sensitive measure of PA by assigning a specific MET level to the activity 
performed (3). This allows investigators to more easily quantify self-report PA 
data collected by questionnaires and examine potential inverse relationships. 
Two studies identified in the literature utilized a PA intensity score (PAIS) . 
(161, 233) to define the PA level and examine the association with the metabolic 
syndrome utilizing the NCEP definition. PAIS is defined by the ratio of work · 
metabolic rate (METs) to resting metabolic rate (RMR) obtained by a self-report 
recall of participation in one or more of the following activities during the past 
month: walking, jogging or running, cycling, swimming, resistance training, 
exercise classes, or yard work (41). - PA was categorized- based on the 
participants, PAI S  (MET equivalent) over the last 30 days. A PAIS of � 3.5 was 
classified as inactive, 3.6 -14.9 was classified as moderately active, and � 15 
was classified as active for both men and women. These specific values 
· designated the 15th and 65th percentile of PA for men and the 25th and 75th 
percentile of PA for women in the US (154). 
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In the Third National Health and Nutrition Examination Survey (NHANES 
I ll), Park et al. (161) utilized the PAIS to define physical inactivity while examining 
the relationship of -being inactive with the metabolic syndrome. Individuals with a 
PA intensity score � 3.5 were designated physically inactive and identified the 
15th and 25th percentiles of adult males and females respectively in the U.S. 
population. In a multivariate odds ratio (OR) model adjusting for ethnicity, BMI ,  
smoking status, alcohol intake, carbohydrate intake, education level in years, 
household income, and menopausal status, neither men (OR 1.4 ;  95% Cl 1.0-
2.0) or women (OR 1.2, 95% Cl 1.0-1.4) classified as physically inactive by a 
PAIS of � 3.5 were found to be at an increased risk for having the metabolic 
syndrome. Therefore, suggesting no relationship between physical inactivity and 
the metabolic syndrome. 
In another study utilizing the same NHANES Il l  dataset and PAIS, Zhu et 
al. (233) examined the relationship of being active, moderately active, and 
inactive based on a PAIS � 15.0 (active), �3.6 to 14.9 (moderately active), and 
�3.5 respectively, with the likelihood of having the metabolic syndrome. Both 
males (OR, 0.41 95% Cl 0.31-0.54) and females (OR, 0.25, 95% Cl 0. 18-0.37) in 
the active group were found to b_e ·less likely to · have the metabolic syndrome 
compared to the inactive group. Following adjustments for BMI , males were 73% 
less likely (OR 0.27, 95% Cl, 0. 18-0.40) and females were 68% less likely (OR 
0.32; 95% Cl, 0.21-0.51) to have the metabolic syndrome if they reported being 
active. In men and women who reported being moderately active they were. 
found to be 34% less likely (OR 0.66; 95% Cl, ·0.48-0.89) and 31  % · less likely 
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(OR 0.69; 95% Cl, 0.48-0.99) to have the metabolic syndrome respectively. 
These findings illustrate a potential inverse association between PA and the 
metabolic syndrome. However among females, after adding age, race, 
education, income, and menopausal status to the model, the protective effect of 
PA disappeared. 
In a cross-sectional sample of 711 white males, Carroll et al. (37) utilized a 
leisure-time physical activity index (PAI) (192) to examine the association 
between LTPA and the metabolic syndrome using the criteria originally put forth 
by Reaven (173). Data from a 4-week history of L TPA was available for 697 of 
the original 7 11 men. These men were asked about their usual L TPA patterns, 
designating regular walking in minutes per weekday (min/wkd), cycling activity in 
minutes per day (min/d), recreational activity in hours per weekend (h/weekend), 
and vigorous activity in times per month (times/m). A PAI score was calculated 
based on frequency,_ duration, and intensity of each activity. Scores were 
assigned for each mode of activity and time spent performing the activity based 
on the intensity and energy requirement of each activity reported (202, 230). 
These men were grouped into four categories: inactive (0-2 consisting of no 
L TPA); occasional/light (3-8 consisting of walking and some more vigorous 
activities); moderate/moderate vigorous (9-20 consisting of cycling or frequent 
sporting activities); and vigorous (� 21 consisting of very frequent sporting and 
recreational activities.) 
When compared to the inactive group, men with a PAI of 3-8 were found 
to be 44% less likely (OR 0.56; 95% Cl , 0.33-0.96) to have the metabolic 
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syndrome. This would equate to performing L TPA 2-3 times per week at 3-4 MET 
level for 30-40 minutes per session, or approximately 300 MET·minwk·1 • Men 
with a PAI of 9-20 were found to be 67% less likely (OR 0.37 95% Cl, 0.1 9-0.7 1 )  
to have the metabolic syndrome. This would equate to performing LTPA 3-4 
times per week at a 5-6 MET level for 30-45 minutes per session, or 
approximately 700 MET·min·wk-1 . Men with a PAI � 21  were found to be 88% 
less likely (OR 0.1 2; 95% Cl, 0.03-0.50) to have the metabolic syndrome and this 
would equate to performing LTPA 4-5 times per week at � a 6.5 MET level for 45-
60 minutes per session, or approximately 1530 MET·min·w1<·1 . A clear inverse 
association was noted for each increase in PAI score. 
Misra et al. ( 150) reported the association between L TPA and the 
metabolic syndrome in a study of Asian Indian immigrants living in Northern 
California. In this study, LTPA was expressed as a score of activity metabolic 
index (AMI) utilizing a Taylor intensity code (202) reported for each type of L TPA 
performed over the last 1 2  months. When examining the risk of metabolic 
syndrome as defined by NCEP, an AMI was calculated for light, moderate, 
heavy, and total L TPA over the last year: 
Total AMI = I: (intensity*months/year) * (frequency/month) * 
(time/session) 
This study found that compared to women, men were twice as likely to be 
active. Also, men and women with the metabolic syndrome reported the lowest 
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levels of L TPA estimated by the AMI . Men engaging in moderate L TPA of 
approximately 88 MET·min·wk·1 and high intensity PA of approximately 180 
MET·min·wk·1 for a total of 268 METmin·wk·1 were found to be significantly less 
likely to have the metabolic syndrome than men performing only light LTPA. This 
association was not seen in women. Women reported performing activities of 
similar intensity to men; however the total number of MET·min·wk·1 of L TPA 
performed by women was less than half of that performed by men. Women 
reported engaging in approximately 203 METmin·wk-1 of PA or 50 total minutes 
of L TPA per week, while men reported engaging in approximately 533 
MET·min·wk·1 of accumulated L TPA or 124 total minutes of LTPA. This 
illustrated an inverse association between PA and the risk of being diagnosed 
with the metabolic syndrome. 
In a study of Aboriginal (native) Canadians examining non-traditional 
cardiovascular risk factors and their association with the metabolic syndrome as 
defined by three different medical societies (103, 155, 223), the association of PA 
with the syndrome was also evaluated (144). The lifestyle for Aboriginal people 
traditionally involved activities of daily living (ADLs) being of the vigorous nature, 
however, over the last 20 years many Aboriginals have drastically reduced -their 
daily PA levels. Data was collected on 360 non-diabetic adults participating in a 
study of Aboriginal Canadians. A previously modified PA questionnaire (125) was 
used to assess PA. Participant PA levels were determined by L TPA and 
occupational activities over the past 12 months. Activity intensity was esti_mated 
so PA could be expressed in MET hours per week (MET·h/wk·1 ). In addition, 
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cardiorespiratory fitness level was estimated utilizing a validated step protocol 
(193) and expressed in mL·kg-1 ·min-1 . 
In a multiple logistic regression model controlling for age, percent body fat, 
smoking status, and fitness level, men who reported engaging in regular PA were 
found to be 4% less likely to have the metabolic syndrome, (OR 0.96; 95% Cl, 
0.93-0.99) for every 5 METh/wk-1 increase in PA. This relationship not observed 
in women (OR 1.00; 95% Cl, 0.98-1.03). However, in the same model with the 
substitution of PA level for CV fitness, men and women were found to be 84% 
and 66% respectively, less likely to have the metabolic syndrome for every 1 O 
ml·kg-1 ·min-1 increase in cardiorespiratory fitness. The stronger association for 
fitness over PA is difficult to explain, but is most likely due to the objective nature 
in which cardiorespiratory fitness was measured compared to the self-report 
assessment of PA (23). In addition to utilizing the WHO (223) definition, these 
investigators when applying the NCEP (155) and IDF (103) definitions did not 
detect any changes in the results. 
· In a national study of over 50,000 Chinese, aged 15- 96, the association 
between low, moderate, and high levels of PA performed at varying intensities 
and the risk of having the metabolic syndrome as defined by the Chinese Medical 
Association was examined (143). Following adjustments for gender, age, 
smoking status, alcohol intake, and BMI, those who reported performing 900 
METmin·wk-1 of low-level PA for were found to 55% less likely to have the 
metabolic syndrome when compared to those who reported performing 450 
MET·min·wk-1 of low-level PA. In addition, Chinese men and women who 
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reported engaging in � 360 MET-min-wk-1 of vigorous PA were found to be 25% 
less likely to have the metabolic syndrome than those reporting < 360 
MET-min·wk·1 of vigorous PA. 
The association between MET hours per week (MET·hr·wk-1 ) of L TPA and 
the likelihood of having the metabolic syndrome was examined in the Whitehall I I  
study of civil servants aged 45-68 years (177). The metabolic syndrome was 
defined as meeting the cut-off points for the sex-specific top quintile, or bottom 
quintile in the case of HDL-C for three or more of the following: post-glucose 
load; SBP; fasting triglycerides; fasting HDL-C; and waist to hip ratio. This was 
done due to the fact that no medical society definition for the metabolic syndrome 
had yet been published; and these quintile cut points were thought to 
representative of a level of increased risk for CVD. Utilizing a modified version 
the Minnesota leisure-time physical activity questionnaire (202), data on 20 
different activities were collected. Activity patterns over the last month were 
ascertained in order to get a notion for habitual activity. Activities were assigned 
a MET value (3) to calculate MET hours per week (MET·h/wk·1 ). MET values for 
activities were grouped into two categories: moderate (METs � 3 to < 5 METs), 
this included walking and yard work, and vigorous (METs � 5). Moderate activity 
was then divided into two categories consisting of < 24 MET·h/wk-1 and � 24 
MET-h/wk-1 . Vigorous activity was divided into four categories: no vigorous L TPA, 
< 5 MET h/wk-1 , � 5 and < 12.5 MET-h/wk-1 , or � 12.5 MET·h/wk-1 . 
Following adjustment for age, gender, smoking status, .alcohol .intake, and_ 
job grade (grade 1 represented the highest job .status and grade 6 represented 
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the lowest job status), individuals reporting � 24 MET·h/wk-1 of moderate L TPA 
were found to be 22% less likely (OR 0.78; 95% Cl, 0.63-0.96) to have the 
metabolic syndrome when compared to those reporting < 24 MET·h/wk-1 of 
L TPA. Those who reported performing some vigorous L TPA, but accumulated < 
5 MET·hr·wk·1 were found to be 31% less likely (OR 0.69; 95% Cl ,  0.52-0.91) to 
have the metabolic syndrome, while those reporting � 5 METs, but < 12.5 METs 
of vigorous L TPA were found to be 23% less likely (OR 0.77; 95% Cl, 0.60-0.99), 
and those who reported engaging in � 12.5 MET·hr·wk-1 of vigorous L TPA were 
found to be 48% less likely (OR 0.52; 95% Cl, 0.40-0.67) to-have the metabolic 
syndrome compared to those reporting no vigorous activity L TPA. 
In a study of 107 middle-aged men participating. in the KIHO Study, L TPA 
and the development of the metabolic syndrome as defined by the WHO was 
examined (131). The inclusion of microalbuminuria in the WHO definition as a 
component of the metabolic syndrome had been challenged· (14,· 110); therefore -
it was excluded from the analysis. The KIHD 12 month LTPA Questionnaire (134) 
was utilized to assess the duration, frequency, and average intensity of the most 
commonly performed physical activities. Low L TPA was defined as < 4.5 METs, 
moderate L TPA was defined as � 4.5 METs, and the cut-off point for vigorous 
L TPA was � 7 .5 METs. The total time in minutes per week (min·wk) for these 
three levels of L TPA was summed. The odds risk ratios for total L TPA, low­
intensity LTPA, moderate and vigorous LTPA, and vigorous LTPA and the 
likelihood of having the meta�olic syndrome were calculated. 
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At the 4-year fol low-up ,  and adjusting for age and BMI ,  men reporting 
engaging in a total amount of L TPA � 487 min ·wk·1 were found to be 47% less 
l ikely (OR 0.53;  95% C l ,  0 .3 1 -0 .92) to have the metabolic syndrome compared to 
men reporting < 270 min ·wk·1 (referent g roup) . In the same model, simi lar 
reductions in  risk were observed in men reporting � 1 80 · min·wk·1 or 
approximately 720 MET·min ·wk·1 of moderate (OR 0 .52 ;  95% C l ,  0 . 30-0 .90) and 
vigorous (OR 0 .37; 95%CI ,  0 .21 -0 .66) L TPA. For vigorous activity, men reporting 
a total of � 60 min ·wk·1 or 450 MET-min ·wk-1 of L TPA were found to be 64% (OR 
0.36;  95% C l ,  0 . 1 9-0 .70) less l ikely to have the metabolic syndrome compared to 
men reporting < 1 0  min ·wk-1 of vigorous activity (referent group) . No association 
between moderate L TPA and metabolic syndrome was observed . This was the 
first longitud inal study reporting the association of L TPA with the development of 
the metabolic syndrome (1 3 1  ) .  
· 1n  another study uti l iz ing the measure of MET·min ·wk·1 of L TPA, the same 
group ( 1 3 1 ) exam ined the association between vigorous LTPA and the 
development of the metabol ic syndrome (223) among low birth weight men (1 29) . 
Data on birth weight and length was gathered on 462 men aged 42, 48,  54, or 60 
years_ at basel ine, in the previously described KIHD Study ( 1 85) .  The researchers 
used the ponderal  index (P l )  which was computed as birth weight in kg/length 
(m3) ( 1 80) . The assessment of L TPA and the classification of the vigorous L TPA 
were described previously ( 1 3 1  ) .  
Men who were underweight at birth accord ing to the Pl  were two times 
more l ikely (OR 1 .98; 95% C l ,  1 .09-3.60) to have the metabolic syndrome than 
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men with a normal Pl_. However, the risk of having the metabolic syndrome 
among low-birth weight men was nullified in those reporting � 25 niin·wk·1 or 188 
MET·min.wk·1 of vigorous L TPA when compared to men reporting < 25 min·wk·1 
or 188 MET·min.wk·1 of vigorous LTPA. This association remained following 
adjustments for child or adult socioeconomic status (SES) and BMI. These 
results illustrate that an active lifestyle can modify health outcomes in what some 
consider a thrifty phenotype (17, 98). Individuals with a thrifty phenotype have a 
smaller body size and lower RMRs, thus making them more susceptible to 
metabolic disorders, particularly in affluent societies (16). 
Physical activity and the risk of the metabolic syndrome as defined by 
NCEP was examined in a sample of tri-ethnic females (105). This study had 146 . 
subjects who were enrolled in the Cross-Cultural Activity Participation Study (4, 
106). The Cross-Cultural Activity Participation Study is a study designed to 
examine PA patterns of women > 40 years of age- of varying race and-ethnic 
backgrounds. A total of 51 white women, 49 African-American wonien, and 46 
Native-American women participated with PA records obtained two times, 30 
days apart. Each activity had the type, duration, and intensity recorded and wa� 
used to calculate MET minutes per day (MET-min/d-1) for moderate and vigorous 
LTPA. Utilizing the compendium of physical activities (3), each.activity had a · 
MET value assigned to it. This allowed the absolute intensity of the L TPA to be 
measured. Women reporting 491 MET·min/d-1 to 1351 MET·min/d-1 of moderate 
intensity L TPA were found to be 82% (OR 0.18 ;  95% Cl, 0.03-0.90) less likely to 
have the metabolic syndrome than women in the least active group. Women 
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reporting any vigorous LTPA were also less likely to have the metabolic 
syndrome compared fo their inactive counterparts; however, due to a power 
issue related to the inverse association observed with vigorous LTPA, this did not 
reach significance. 
In the Kuopio tschemic Heart Disease Study ( 1 32) (KIHD) a cross­
sectional association of self-reported LTPA and the risk of having the metabolic 
syndrome as defined by the WHO (223) was examined. The KIHD included 
1 ,069 middle-aged men free of diabetes and CVD at baseline. The validated 
KIHD 12-month L TPA questionnaire assessed the duration, frequency, and mean 
intensity of LTPA over the previous year. LTPA was defined as low-intensity 
which corresponded to < 4.5 metabolic equivalents (METs), and at least 
moderate intensity, which was defined as � 4.5 METs. Three Categories of L TPA 
were then created with tertiles of L TPA in minutes per -week (min/wk) in each 
category: total minutes of L TPA, MET·min,wk·1 · of low-intensity L TPA, and 
· MET·min·wk·1 of moderate and vigorous LTPA. - -
After adjusting for age, men reporting < 217 mi11/wk·1 of total LTPA were · 
found to·be 64% more likely (OR 1 .64; 95% Cl, 1 �oB-2.49) to have the metabolic 
syndrome than men reporting � 409 min/wk·1 of total L TEA . Low-intensity L TPA 
was not found to be associated with the metabolic syndrome. However, men 
reporting < 360 MET·min·wk-1 of at least moderate and vigorous L TPA were 
found to have a similar increase in risk for having the metabolic syndrome as 
men reporting < 2 1 7  min/wk·1 of total LTPA (OR 1 .63; 95%· CI, 1 .07-2.48). Thus, 
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men reporting engaging in low-levels of L TPA, regardless of the intensity level, 
were found to be at an increased risk for having the metabolic syndrome. 
In a sample from the HERITAGE Family Study (117), the efficacy of a 20 
week aerobic exercise training program was evaluated for treating the metabolic 
syndrome (117, 155). There were 621- black and white participants, aged 17 to 
65 years, who met the inclusion criteria of being healthy and sedentary adults 
with BP < 160/100 mmHg. The metabolic syndrome prevalence was calculated at 
baseline and at the end of the 20 week exercise program. Participants began 
exercising three times per week, 30 minutes per session at 55% of their V02 max, 
or approximately 360 MET·min·wk-1 for the first two weeks and eventually 
progressed in the 20 week program to exercising three times per week for 30 
minutes at 75% V02 max, or approximately 550 METmin·wk-1 . Following baseline 
analysis, 105 of the 621 participants were found to have the metabolic syndrome, 
thus the prevalence was 16.9% for the entire study sampla The prevalence of · 
the metabolic syndrome was similar for black men, white men, and black women, 
however, white women were found to have a lower prevalence. 
Following the 20 week exercise program, 32 of the 105 participants 
classified with the metabolic syndrome at baseline no longer had the syndrome. 
In addition, there were no differences between the 32 participants who no· longer 
had the metabolic syndrome and the remaining 73 participants who still had the 
syndrome in terms of age or current fitness level. Consequently, the prevalence 
in this study sample dropped from 1 6.9% to 11.8%. This was the first study to 
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report the usefulness of regular PA in the simultaneous improvements of the 
constellation of risk factors that make up the metabolic syndrome. 
Santos et al. (187) evaluated the association between PA, hours spent 
sleeping, alcohol and smoking habits with the risk of the metabolic syndrome. 
Self-report data was collected on 2, 164 adults (1,332 women; 832 men), ·aged 
18-92 years. PA data was collected from occupational (included transport to·and 
from work), domestic and L TPA domains over the previous 12 months. A MET 
level was assigned to each group of activities and these groups were categorized 
as very light, light, moderate and heavy activities with the corresponding mean 
MET values of 1.5, 2.5, 5.0 and 7.0 respectively. MET values were then 
multiplied by the duration of each activity in minutes per day. Participants MET 
hours per day (MET/h/d) were then divided into tertiles for all three domains of 
PA and total PA. 
Following adjustment for age, education, smoking, and alcohol intake 
women in the upper tertile of total PA (1.54-3.46 MET/h/d) were found to 37% 
less likely (OR 0.63; 95% Cl, 0.43-0 .94) and men in the upper tertile of total PA 
(1.59-4.29 MET/h/d) were found to be 45% (OR 0.55; 95% Cl, 0.33-0.91) less · . 
likely to be diagnosed with the metabolic syndrome compared those in the lowest 
tertile. When examining the other three PA domains individually, there was no 
association found in men for occupational, domestic, or L TPA with the metabolic 
syndrome. However, women received the same level of protection from upper 
tertile of occupational PA (OR 0.63; 95% Cl, 0.40-0.99) as they did from the 
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upper tertile of total PA (OR 0.63; 95% Cl, 0.43-0.94). There was no association 
found in women for domestic or L TPA with the metabolic syndrome. 
These results suggest that L TPA by itself may not be sufficient in reducing 
the risk of being diagnosed with the metabolic syndrome. Total PA accumulated 
from all domains may be more important -in attenuating metabolic syndrome risk. 
Also, women with physically active jobs may receive protection from the 
metabolic syndrome. 
The association between regular PA and the risk metabolic syndrome has 
also been examined in older adults (90). In a cross-sectional study examining PA 
and its association with the metabolic syndrome as defined by NCEP, over 4,000 
men and women, 60 years of age and older were surveyed. PA over the past 12 
months was categorized into four groups: 1) Low PA of < 240 MET·min·wk·1 
representing a sedentary lifestyle; 2) Light PA (�240 MET·min·wk·1 , generally 
without sweating, although not a good marker for PA intensity (219)); 3) 
moderate PA (approximately 360 MET-min·wk·1 , regularly active one to two times 
per week for at least 30 minutes per session); and 4) High PA (�360 
MET·min·wk-1 . )  The results of this study indicated an inverse association 
between regular PA and the metabolic syndrome. Compared to group 1 (< 240 
MET-min·wk·1), participants reporting at least 240 MET-min·wk·1 (group 2) of PA 
were found to be 50% less likely (OR 0.50; 95% Cl, 0.40-0.64) to have the 
metabolic syndrome. Those reporting at least 360 MET;min·wk·1 (group 3) were 
found to be 57% less likely (OR 0.43; 95% Cl, 0.32-0.58), and those reporting � 
360 MET·min·wk-1 were found to be 67% less likely (OR 0.33 ;  95% Cl, 0.22-0.51) 
65 
to have the metabolic syndrome. Hence, a clear inverse association between PA 
and the metabolic syndrome was seen in this study of older adults.· 
Summary of physical activity and the metabolic syndrome literature 
In the literature, there is a consistent inverse association found between -
participation in regular PA and the likelihood of having the metabolic syndrome. 
An inverse association between PA and the likelihood of having or developing 
the metabolic syndrome was observed in more than half the studies cited in this 
- review. Physically active study participants were found to be 4% to73% less likely 
to have the metabolic syndrome compared to their inactive peers. This 
association is influenced by the study population, study design, and how PA is 
measured. The minimum effective dose is not well defined, but . a total of � 150 
m1n·wk of moderate PA or � 60 -min ·wk-1 of vigorous PA appears to be associated 
with a reduced risk of having or developing the metabolic syndrome. When 
examining absolute volume of PA with metabolic syndrome risk, protection 
appears· to start at approximately 300 MET-min·wk-1 , which could be 
accomplished by taking a 30 min walk at a moderate intensity (3-4 METs) three 
of four times pef week. 
There were many limitations reported in these studies. The lack of data on 
frequency, duration, intensity, and mode of PA was not available in many studies, 
thus excluding a true absolute measure of PA volume from being utilized. The 
self-report nature of survey (questionnaire) data is subject to recall bias. The PA 
questions in most of these studies focused on L TPA only. Some questionnaires 
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utilized in these studies have not been validated. Three-quarters of the studies 
identified were of the cross-sectional nature, · thus causality is unable to be 
established. To date, there have only been two studies examining muscular 
strength and the risk of the metabolic syndrome, and they were both in men . . 
Future physical activity and metabolic syndrome research needs 
Studies of PA and metabolic syndrome risk should focus on the strength 
of the inverse association. It has been established that approximately 30 minutes 
of moderate activity on most days of the week or approximately 60 min of 
vigorous activity performed at least 3 days per week will reduce the risk of the 
metabolic syndrome. Furthermore, some-studies appear to show different 
associations for PA and metabolic syndrome risk between genders. Future 
studies are needed to examine the association disparity between genders. 
Furthermore, the effects of resistance training (i.e., muscular strength) on 
metabolic syndrome risk, warrant co·ntinued investigation in men and need to be 
evaluated in women. 
Summary 
The current prevalence estimates of the metabolic syndrome around the 
world range from a low of 7.8% -(7) to a high of 39.1 % (75). These prevalence 
estimates vary depending .on the population being studied and the metabolic . 
syndrome definition utilized. Prevalence appears to greater in nien and increases 
with age. The greatest impact on metabolic syndrome prevalence is the medical 
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society definition applied to a study population. Several studies have utilized 
various definitions of the metabolic syndrome, thus making it difficult to make 
comparisons between studies. The core components (glucose, obesity, 
dyslipidemia, and HTN) are similar in all the commonly utilized working 
definitions (46, 85); however, the cut-off points for each condition are not 
consistent among definitions. With comparison of two different definitions in the 
same population, prevalence estimates of the metabolic syndrome have been 
shown to differ (75, 76), thus definition utilized has been shown to have an 
impact on prevalence. 
In all 25 studies identified in the literature that have examined the 
association of PA with the metabolic syndrome, a consistent inverse association 
or suggestion of potential protection was found between participating in regular 
PA and the likelihood of having or developing the metabolic syndrome. Some of 
these studies found the favorable effects of PA to be limited to a specific gender 
(54, 78). However, in the majority of the studies that included both men and 
women, some level of protection from being physically :active was observed. 
Overall, it appears as the volume of PA increases, the likelihood of having or 
developing the metabolic syndrome decreases. The precise amount of PA 
necessary to elicit a reduced risk of the metabolic syndrome is not well defined, 
however, current research illustrates that meeting the recent public health 
recommendation for PA (162) would be prudent. 
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The .purpose of this study was to examine the relationship between 
Leisure-Time Physical Activity (LTPA) and the likelihood of having the Metabolic 
Syndrome in a nationally representative sample of the United States (U.S.) adult 
population. The following section furnishes a detailed description of the 
methodology that was utilized in this study. The study employed secondary data 
analysis of the most recent release of the 1999-2004 National Health and 
Nutrition Examination Survey (NHANES). This section includes a discussion of 
the subjects, a description of NHANES 1999-2004, variables of interest, and data 
analysis. 
Subiects 
The subjects included in this study participated in the 1999-2004 NHANES 
(6). NHANES is conducted by the National Center for Health Statistics (NCHS) 
and is a continuous survey that regularly releases public use data as smaller · 
component-specific files (3). The most recent survey was conducted from 1999 
through 2004 and represents the eighth series of NHANES. The total sample N 
for the most recent six years of data released from N HAN ES was 3 1, 126 and 
included individuals two months of age and above. The final sample for this study 
was 5,620 U.S. aduits � 20 years of age who were given a clinical exam following 
an overnight fast (minimum 8 hours). 
The sample for this study met the following conditions: 1) adult men and 
women � 20 years of age; 2) attending a morning MEC examination following a� 
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overnight fast; 3) if a women, not pregnant; and 4) had provided complete data 
on all the variables· of interest. 
Data Col lection 
Data were collected from a nationally representative sample of U.S. 
adults, � 20 years of age (N= 31,126) living in residences that were selected in 
NHANES 1999-2004. All eligible study participants, o-r their guardians, were 
provided with and signed an informed consent describing the details of the 
survey. All information collected was kept confidential in accordance with the 
· Public Health Service Act and the Privacy Act of 197 4 (15). The main objectives 
of NHANES are to estimate the prevalence of various diseases and risk factors in 
the U.S. population in order to monitor trends for treatment and control (6). 
NHANES also provides information on risk factors for known diseases in order to 
study the relationship between behavior, environment, and health. 
The NHANES studies are conducted by the NCHS, which is-a federal 
agency that collects health data for the U.S. (3). The NHANES survey design is a 
stratified, multistage probability sample of the noninstitutionalized U .S. civilian . 
population over the age of two months. The stages of the sample selection 
include the following: 1) primary sampling unit (PSU) selection; 2) selection of 
PS Us in each segment; 3) selection of residence in each PSU; and 4) 
interviewing at least one person in each household. The 1999-2004 NHANES 
over-sampled low-income persons, adolescents , persons 60 years of age and 
older, and minorities (3). Previously, NHANES were conducted on a periodic 
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basis and data were released in single data set covering multiple years . . 
Beginning in 1999 , NHANES has been conducted as a continuous survey, 
releasing public use data continuously as smaller component-specific data in 
two-year phases. For example, NHANES 1999-2004 data were released as 
NHANES 1999-2000, NHANES 2001-2002, and NHANES 2003-2004. 
Each year nearly 7,000 people are interviewed by trained interviewers in 
the participants' place of residence. Approximately 5,000 of the people 
interviewed in their homes also complete a health examination survey conducted 
in a mobile examination center (MEC). If an individual is unable to attend the 
MEC, they may receive a health examination at home (6) . All interviews are 
recorded using a computer assisted personal interview (CAPI) system. Eligible 
participants who are 16 years of age or older are interviewed without a guardian, 
but those participating in the survey under the age of 16 are interviewed with ·a 
parent or guardian (5) . These health surveys include questions regarding a wide 
breadth of health and nutrition related issues (e.g. ,  has you doctor ever told you 
that you have diabetes?) . 
Participants, who attend the MEC for the health e�amination component, 
are examined by a wide range of health professionals. Each MEC team is made 
up of one doctor, one dentist, two dietary personal, three certified medical 
technologists, five health technicians, one phlebotomist, two trained interviewers, 
and a data manager (6) . Standardized medical examinations are completed 
including measurements directly associated with the metabolic syndrome and 
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PA. These measures include blood pressure, lipoprotein values, glucose levels, 
waist circumference, and urinanalyis. 
Measures 
Dependent measure(s}: The Metabolic Syndrome 
The dependent variable· in this study was a positive diagnosis of the 
metabolic syndrome based on the American Heart Association and the National 
Heart, Lung, and Blood Institute (AHA/NHLBI) criteria (9). In 2005, the American 
Heart Association and the National Heart, Lung and Blood Institute issued a new 
definition which serves as an updated version of the NCEP criteria (9). The 
majority of research that has been done on the metabolic syndrome and PA has 
involved the use of the NCEP (14) criteria, which preceded the AHA/NHLBI 
definition. 
The AHA/NHLBI definition requires that three of the following five risk 
factors be present for a diagnosis of the metabolic syndrome: 1) impaired fasting 
glucose (IFG) � 100 milligrams per deciliter (mg/dl) or undergoing 
pharmacological treatment; 2) low high-density lipoprotein cholesterol (HDL-C) < 
40 mg/dl in men or < 50 mg/dl in women, or undergoing pharmacological 
treatment; 3) triglycerides � 150 mg/dl or undergoing pharmacological treatment; 
4) a waist circumference 0/VC) > 102 centimeters in men or > 88 cm in women; 
and, 5) blood pressure � 130/85 mm/Hg or undergoing pharmacological 
treatment for hypertension (HTN). The AHA/NHLBI definition is unique in the 
respect that it precludes specific inclusion criteria of any one condition (e.g., I FG) 
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in order for metabolic syndrome to be diagnosed. This most recent definition put 
forth by the AHA and NHLBI mirrors the NCEP definition with the following 
modifications: _pharmacological treatment for those with dyslipidemia, HTN, and 
IFG are positively identified to the respective criteria for diagnosis. In addition, 
the cut-off point for IFG was lowered from 110 mg/dl to- 100 mg/dl to reflect the 
recent changes issued by the American Diabetes Association (ADA) for IFG (1). 
A comparison of this definition to other metabolic syndrome medical society 
definitions can be found in Table A-1 in Appendix A. 
In creating a dependent variable based on a positive diagnosis of the 
metabolic syndrome utilizing the AHA/NHLBI definition (METyes), data on blood 
pressure, fasting glucose, lipoprotein values, and WC measurements were· 
utilized from the MEC related data from the health examination component of the 
survey. Each criterion was dichotomized with the demarcation being the cut-off 
value for inclusion as a component of the metabolic ·syndrome. For example, the 
following is a recode for -blood pressure (BP) that was utilized in our-study: 
If 130<=bpxsar or 85<=bpxdar or bpq050a= 1 then AHAHTN= 1 ; ·_ 
else if bpxsar<130 and bpxdar<85 or bpq050a=2 then AHAHTN=O; . 
If a person was found to have a systolic BP (code=bpxsar in NHANES data file) � 
130 or a diastolic BP  (code=bpxdar in NHANES data file) � 85 or undergoing 
. pharmacological -treatment for HTN (code=bpq050a in NHANES data file) they 
were coded a 1 for having HTN. 
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Metabolic syndrome risk score (MSRS): 
In creating a dependent variable based on a positive diagnosis of the 
Mets utilizing the AHA/NHLBI definition, data on blood pressure, fasting glucose,­
lipoprotein values, and WC measurements were utilized from health examination 
component of the NHANES. Each CV risk factor was dichotomized with the 
demarcation being the cut-off value or pharmalogical treatment for inclusion as a 
component of the Mets (O= no risk; 1 = risk). Risk factors were summed and a 
total metabolic syndrome risk score (MSRS) was calculated which ranged from 0 
(no risk factors) to five (all five risk factors present). Those subjects with a score 
of 0-2 risk factors were determined not to have the Mets and those respondents 
with a score of 3 to 5 risk factors were determined to have the Mets. 
Independent measures 
A variety of variables were utilized as independent factors in this study. 
The primary independent measure of in this study was L TPA. All other 
independent measures were treated as controlling measures. 
Leisure-Time Physical activity {L TPA}: Data utilized to measure PA were 
collected from two distinct NHANES files. The PA and physical fitness file 
,,. (PAQ_C) and the PA individual activities file (PAQIAF) from the household 
·questionnaire and MEC interview (4). The PAQIAF is the second of two files on 
PA and includes more detailed information regarding 43-specific types of 
moderate and vigorous leisure-time activities. This study utilized L TPA data from 
the PAQIAF. The following codes were used to identify the characteristics of PA: 
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+ PADACTIV: Numeric code for specific type of PA reported. 
+ PADTIMES: Frequency reported for the activity over the past 30 days. 
+ PADDURAT: Average amount of time (in minutes) spent during each 
activity session. 
+ PADIVlETS: Metabolic equivalent (MET) score assigned to each activity 
utilizing the compendium of physical activities (2). 
The information from the PAQIAF allowed us to create a sensitive measure of PA 
to examine the relationship with the metabolic syndrome. Taking the number of 
times an activity was done over the last 30 days and calculating how many times 
per week the activity was performed provided a frequency per week. Util izing the 
compendium of PA and assigning the appropriate MET level to the type of 
activity performed provided us with the intensity of .the specific activ�ty. METs 
represents the oxygen uptake for that activity in m�·kg-1 ·rnin·1 divided by 3.5 
ml·kg-1 ·min·1 (10). Then, taking the average duration (minutes per session) , the 
average frequency (number of sessions per week) and the intensity level (MET­
level) assigned to the activity, we calculated MET minute.s per week 
(MET·min·wk·1) .  This was done for each LTPA performed._ The sum of all 
MET·min·wk·1 performed produced a 11total MET·min·wk-1 " measure. The 
following is an example E>f a calcu lated LTPA MET·min·wk·1 value from an earlier--­
pilot study that examined the relationship of L TPA with the metabolic syndrome 
according to the NCEP definition (See Appendix B) : 
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Frequency (5 sessions per week) x Intensity (4 METs) x (Duration 30 minutes/session) 
= 600 MET·min -wk·1 
In order to e�amine a possi�le inverse as�ociatipn for L TP� and the 
metabolic syndrome, MET·min·wk·1 was divided into a six-level ordinal variable . 
..,. _  
The first level represented those wh� were physically inactive, the referent group 
for this study. This level included all individuals who reported no moderate or 
vigorous L TPA. Thus, they were assigned a score of "O" MET·min·wk·1 . In 
calculating the remaining five levels of this measure, the Met·min·wk·1 was 
divided into quintiles from the METmin·wk·1 measure. This was done for two 
reasons: 1) to accou_nt for the non-normally distributed and skewed_ data that is 
inherent to national population surveys (11), and 2) to provide a greater level of 
precision when looking for a potential inverse association. 
� s�cond measure used focused on whether this possible inverse 
association transfers over to a three-level categorical variable based on the 
Centers for Disease Control and Prevention and the American College of Sports 
Medicine (CDC/ACSM) public health recommendation (18). Individuals who 
were found to meet the CDC/ACSM PA recommendation of five days per week of 
moderat� intensity L TPA for 30 minutes, or three days per week of viggrous 
intensity L TPA far 20 minutes were classified as meeting the public health· 
recommendation; individuals who were found to engage in L TPA at least one 
Jime per w��� but no! meeting the CDC/ACSM recommenda_tion were classified 
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in the some, but insufficient category. Those who reported performing no LTPA 
were classified as inactive. 
Other independent measures 
Additional factors that were controlled for included- five demographic 
variables; age, race/ethnicity, and two markers of socioeconomic status (SES), 
education and income. 
Age was categorized into seven, 10-year age-groups: 20-29, 30-39, 40-
49, 50-59, 60-69, 70-79, and � 80. The division of age into 10-year age-groups 
allowed testing for a more precise possible inverse association of PA. 
Education 
Education was divided into three categories. - Completing less than 1 ih 
grade (referent group), completing 12th grade, or education beyond 1ih grade. 
Income 
Income was categorized as percent of poverty thresholds (< 100%, 100% 
to 199%, 200% to 299%, 300% to 399%, > 400%). The standardized poverty 
threshold represents dollar amounts that define poverty status while accounting 
for family size 
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(www.census.gov/hhes/www/poverty.html). Falling below a poverty threshold of 
100% demarcates living in poverty. 
Further adjustments were made for alcohol consumption, smoking status, 
and family history of chronic disease, including heart disease and diabetes. All of 
these preceding variables may impact the cardiovascular disease risk factors that 
define the metabolic syndrome, and will be briefly discussed below. 
Alcohol intake 
Alcohol intake in moderation has been shown to have favorable effects in · 
people with the metabolic syndrome (8). In NHANES, alcohol intake is assessed 
over the previous 12 months. Moderate alcohol intake is classified as one drink . · 
or less per day in women, and two drinks or less per day in men. In this study, a 
three level categorical variable was created; 1) above moderation drinker, 2) 
moderate drinker, and 3) non.;.drinker. 
Smoking 
Smoking is a primary risk factor for coronary heart disease (16, 21 ), 
however, the effects of smoking on the metabolic syndrome-are equivocal (13, 
17). In this study, smoking status was divided into three categories: 1) current 
smoker, 2) previous smoker, and 3) non-smoker. The three categories allow a 
more precise examination of the potential effects of smoking versus using a 
dichotomized variable. 
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Family history of chronic diseases 
Family history of chronic diseases included two conditions; heart disease 
and diabetes. The initial definition put forth by NCEP (14) and the updated 
AHA/NHLBI (9) definition were created to help identify thos� at high-risk for these 
two conditions. For a subject to be classified with a positive family history for · · 
heart disease or diabetes, he/she must have reported that either a parent and/or 
sibling have had the condition. These two variables were dichotomized, family 
history yes/family history no. 
Data Analysis 
Weighting 
A variety of procedures were used to prepare the data for analysis. This 
section discusses data preparation, data management, and recoding. Weighting 
issues, as well as statistical analysis were run in SUDAAN (19) due to the 
correlated multi-stage design inherent in NHANES. 
NHANES is a complex survey sample (5) . The design and weighting 
methods utilized in NHANES have been similar over the history of the survey. 
Sampling weights must be used to account for: 1) probability selection (multi­
stage) , 2) over-sampling of non-Hispanic Blacks, Mexican-Americans, low­
income persons, adolescents aged 12-19 years, and persons over 60 years of 
age, 3) and non-response rates to interview and examination components (i. e. , 
missing data) . Sampling weights produce unbiased national estimates (3) . "The 
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sample weight of a sampled person is the estimated number of individuals in the 
population which the person represents" (12). 
A six-year weight for each person who attended the MEC following a 
morning fast was created for this study. Fasting weights provide national 
representative population estimates based on a sub-sample who attended the ·­
morning MEC examination in fasting conditions. Using a provided fasting weight 
variable in the N HANES data set, the six-year weight variable was created by 
taking 2/3 of the four year weight for each person sampled in 1999-2002 
(WEIGHT6=2/3*WTSAF4YR) and 1/3 of the two year weight for each person 
sampled in 2003-2004 (WEIGHT=1/3*WTSAF2YR). The final six-year weight 
variable was WTSAF6YR (3). 
Variance estimation 
Variance estimation or sampling errors were also addressed. Following 
the NHANES 1999-2000 release of the data as public use files, confidentiality 
principles prohibited the release of the PSU variable. In  the 1 999-2000 N HANES, 
replicate weights were produced and a jackknife procedure was recommended 
for variance estimation (7). However, this procedure was not applicable for 
multiple two-year data sets. The new method for variance estimation protects 
confidentiality and allows the use of PSUs: ThisrtOVel approach creates Masked 
Variance Units (MVUs) which can be used to estimate sampling errors. These 
MVUs have been developed in a way that permits them to be utilized with any 
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combination of data without recoding. Data were sorted by the design variables 
SDMVSTRA and SDMVPSU before analysis (3). · 
Statistical Analysis 
A total of 54 data files were downloaded and managed in this study. The 
data were initially managed utilizing SAS 9.1 (20). SAS was used to conduct both 
complex variable recodes and data coding validation. 
SAS-callable SUDAAN (19) was then utilized to conduct the. analysis 
regarding the three research questions posed in this study. SUDAAN 
incorporates sampling weights within the context of the correlated multi-stage 
complex sampling design inherent to NHANES (3). Research question 1: "What 
is the current prevalence of the Metabolic Syndrome in the United States adult 
population according to the National Heart, Lung, and Blood Institute definition?" 
will be answered 'using PROC DESCRIPT. PROC DESCRIPT allows age­
adjusted prevalences to be estimated. The age-adjusted prevalence of the 
metabolic syndrome was computed using the direct method based on the 2000 
U.S. population (22). 
Logistic regressioA using PROC RLOGIST was used to estimate odds 
ratios for being diagnosed with the metabolic syndrome (metabolic syndrome yes 
versus metabolic syndrome no) in addressing research questions 2 and 3. For 
research question 2, " Is there an inverse association for L TPA and the metabolic 
syndrome when utilizing a measure of L TPA volume (MET·min·wk-·1)?" a logistic 
regression model was utilized for the six-level MET·min·wk·1 independent 
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measure to focus on a possible inverse association. Research question 3, "Is 
there an inverse association for physical activity and the metabolic syndrome 
when measuring physical activity from the parameters of the CDC/ACSM 
physical activity public health recommendation?" PROC RLOGIST was also 
utilized to estimate the likelihood of having the metabolic syndrome based on 
meeting the current public health PA recommendation (18), being active but not 
meeting the recommendation, and being physically inactive. Multiple logi�tic 
regression (PROC MUL TILOG) was then used to estimate the OR and 95% Cl of 
accumulating additional CV risk factors using the MSRS as the dependent 
variable with L TPA being the primary independent variable. 
Limitations 
Aspects of the NHANES 1999-2004 may limit the findings in this study. 
The most recent data from NHANES were collected from 1999 to 2004, thus the 
prevalence estimates of the metabolic syndrome and the association with PA 
may not reflect the association in the current U.S. population. PA data was self- : 
report over the past 30 days, thus frequency, intensity, duration, and type of PA 
is subject to recall bias. While cognitive te_sting has been done, the reliability and 
validity of the PA has not been tested. Furthermore, this was a cross-sectional 
study, thus causality cannot be established. 
116 
Summary 
The three research questions in this study were: 1) "What is the current 
prevalence of the Metabolic Syndrome in the United States adult population 
according to the AHA/NHLBI definition?", 2) "Is there an inverse association for 
L TPA_ anc;I the metabolic syndrome when utilizing a measure of L TPA volume 
(MET·min·wk-1)?", and 3) " Is there an inverse association for physical activity -and · 
the metabolic syndrome when measuring physical activity from the parameters of 
the CDC/ACSM physical activity public health recommendation?" The questions 
are presented to estimate the current prevalence of the metabolic syndrome and 
to examine the relationship between L TPA and the metabolic syndrome 
according to the AHA/NHLBI definition in the U.S. adult population. 
This is the first study to estimate metabolic syndrome prevalence and to 
utilize the most sensitive measure of L TPA volume (MET·min·wk-1) to examine 
the possible inverse association of L TPA with the METs in the U.S. adult 
population using the most recent metabolic syndrome definition put forth. by the 
AHA and the NHLBI. 
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PART IV 
The Relationship Between Leisure-Time Physical Activity and the Metabolic 
Syndrome Among U.S. Adults: NHANES 1999-2004 
1 22 
ABSTRACT . 
Healthy People 201 0  identifies the metabolic syndrome metabolic syndrome as 
an emerging health issue within the realm of cardiovascular (CV) disease. The 
metabolic syndrome is a clustering of five CV risk factors that include poor 
glucose control or diabetes, overweight/obesity, hypertriglyceridemia, low high­
density lipoprotein cholesterol (HDL-C) , and hypertension (HTN). An individual 
that possesses three or more of these CV risk factors would be classified as 
having the metabolic syndrome (15). The prevalence of metabolic syndrome in 
adults is reaching epidemic proportions in the United States (U.S.) and 
worldwide. Purpose: The purpose of this study was to two-fold. First, this study 
examined the possible inverse relationship between leisure-time physical activity 
(L TPA) and the metabolic syndrome. Secondly, this study evaluated the current 
prevalence of the metabolic syndrome metabolic syndrome in a nationally 
representative sample of the (U.S.) adult population within the 1 999-2004 
National Health and Nutrition Examination Survey (NHANES). Methods: The 
sample for this study-included adults, 20 years and older, (N=5,620) who 
completed the mobile examination center (MEC) examination in the 1999-2004 
NHANES. · The American Heart Association and National Heart, Lung, and Blood 
Institute (AHA/NHLBI) definition was used to define the metabolic syndrome. A 
metabolic syndrome risk score (MSRS) ranging from O (no risk factors present) to 
5 (all five risk factors present) was created to sum CV risk factors in which 
accumulating a MSRS �3 confirmed a metabolic syndrome diagnosis. Physical 
activity (PA) was measured in two ways: a six-level measure based upon those 
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reporting no L TPA (0 MET·minutes per week) and quintiles of L TPA, and a three­
level measure (no L TPA, insufficient L TPA, and L TPA level meeting· CDC/ACSM 
PA recommendation) associated with the current Centers for Disease Control 
and American College of Sports Medicine public health PA recommendation. 
SUDAAN statistical software was used to estimate age-adjusted metabolic 
syndrome prevalence with logistic and multi-logistic odds risk ratios used to 
examine the possible inverse association between L TPA and the metabolic 
syndrome. Results: The overall age-adjusted prevalence of the metabolic 
syndrome among the U.S. adult population was 36.3%. Adults who acquired 
between 736 and 1360 MET·min-wk·1 of L TPA were found to be 35°/o (OR 0.65; 
95% Cl 0.48-0.88) less likely to meet the AHA/NHLBI metabolic syndrome 
diagnosis criteria compared to those reporting no L TPA. A similar inverse 
association was found against an increasing MSRS (OR 0.69; 95% Cl 0.56-
0.85). A stronger inverse relationship was noted for those accumulating a weekly 
· 1evel of L TPA MET-minutes coinciding with 60 ·minutes per day of moderately 
intense PA (OR 0.55 ; 95% Cl 0.42-0.71). Similarly, this inverse association was 
also (OR 0.58; 95% Cl 0.48-0.70) found at the same level of L TPA against an 
increasing MSRS. Furthermore, a significant inverse association (OR 0.61; 95% 
Cl 0.48-0.77) was also found for the metabolic syndrome when examining LTPA 
by the CDC/ACSM public heath PA recommendation. Similar to L TPA 
MET·minute volume, this inverse association (OR 0.64; 95% Cl 0.53-0.77) 
carried over to the MSRS. Conclusion: Findings estimate one in three U.S. 
adults have the metabolic syndrome which is consistent with other recent studies 
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conducted using NHANES. This study consistently showed an inverse 
association between L TPA the metabolic syndrome and underlying CV risk 
factors . Whi le this study is cross-sectional and causality ·cannot be inferred , our 
findings do i l lustrate an inverse association between LTPA and the metabolic 
syndrome. These results support the need for future longitud inal stud ies and 
randomized control trials examining PA volume and metabolic syndrome risk. 
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Introduction 
Healthy People 2010, the national health objectives for the United States, · 
identifies the metabolic syndrome metabolic syndrome as an emerging health 
issue within the realm of cardiovascular (CV) disease (27). The metabolic 
syndrome is a clustering of five CV risk factors that include poor glucose control 
or diabetes, overweight/obesity, hypertriglyceridemia, low high-density lipoprotein 
cholesterol (HDL-C), and hypertension (HTN). An individual that possesses three 
or more of these CV risk factors would be classified as having the metabolic 
syndrome. The prevalence of metabolic syndrome in adults is reaching epidemic 
proportions worldwide ( 14) and it has recently been reported that one in three 
American adults currently have the metabolic syndrome (11 ). This is important 
because a metabolic syndrome diagnosis carries a two-fold increase in coronary 
heart disease mortality (CHO) (12, 22) and a 40% increase in all-cause mortality 
(22). 
Researchers studying the metabolic syndrome and its underlying CV risk · . 
factors have, to a large degree, focused on identifying the lifestyle behaviors that 
might put a person at risk. One lifestyle-related behavior, physical activity (PA), 
has been found to be consistently and inversely associated with metabolic 
syndrome risk. As noted in a recent review by Ford et al. (14), · a large 
contribution to our knowredge of a beneficial inverse relationship found between 
PA and metabolic syndrome comes from research that has used nationally 
representative population-based surveillance systems - one of which is the 
National Health and Nutrition Examination Survey . (NHANES) (7). NHANES (7) is 
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one of only a few surveillance systems around the world using a nationally 
representative sample that simultaneously measures all of the CV risk factors 
making ·up the metabolic syndrome, in addition to measuring PA. To date, four 
studies have utilized the NHANES to explore the relationship between_ PA and 
the metabolic syndrome (9, 13, 23, 28). 
Three studies utilized data from the 1988-1994 NHANES I ll. 
Unfortunately, these PA and metabolic syndrome studies were limited in that the 
assessment of PA only focused on the frequency and intensity of LTPA, with the 
duration of L TPA being absent. Despite this limitation, we still gained some 
insight into the relationship of the metabolic syndrome with PA. Park et al. (23) 
was the first to explore the association of PA with the metabolic syndrome 
utilizing a physical activity intensity score (PAIS) to measure the volume of L TPA. 
The PAIS was defined by the ratio of work metabolic rate (METs) to resting 
metabolic rate (RMR) obtained by a self-report recall of participation in various 
types of L TPA over the previous 30 days (8). Creating a dichotomized variable 
for LTPA (active versus inactive) based on the ·PAIS, neither physically inactive 
men (OR 1.4; 95% Cl 1_ .0-2.0) or women (OR 1.2, 95% Cl 1.0-1.4) were found to 
be at an increased risk for having the metabolic syndrome. 
In another study utilizing the same NHANES I l l  dataset and the L TPA 
PAIS, Zhu et al. (28) created a three-level categorical variable: active (PAIS � 
· 15.0), moderately active (PAIS �3.6 to 14.9), and inactive (PAIS �3.5) to allow a · 
broader range of LTPA volume to be examined. After controlling for lifestyle- · 
related risk factors, males (OR 0.41; 95% Cl ·O .31-0�54) and females (OR 0.25; 
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95% Cl 0.18-0.37) in the most active PA group were found to be significantly less 
likely to have the metabolic syndrome compared to the inactive group. Adults in 
the moderately active group were not associated with a reduced risk for the 
metabolic syndrome. 
More recently, Du Bose et al. (9) utilizing data from NHANES Ill examined 
the relationship between LTPA and the metabolic syndrome-using a three level 
categorical variable to define L TPA (inactive, irregularly active, and regularly 
· active) with the regularly active level of L TPA representing the Centers for 
Disease Control and Prevention and the American College of Sports Medicine 
CDC/ACSM PA public health recommendation (24) . Adults reporting being 
inactive (no LTPA) were found- to be 45% (OR 1.45; 95% Cl 1: 17-1.79) more 
· likely to have the metabolic syndrome compared to those reporting being 
regularly active. 
The most recent NHANES, beginning in 1999, measured PA from three 
domains; L TPA, transportation, and domestic (7). In addition, this current . 
NHANES collected more detailed information on PA, including frequency, 
intensity, and duration. As a result, the current NHANES allows for a more 
p·recise examination of PA volume with the metabolic syndrome and other 
chronic diseases. Ford et al. (13), using data from NHANES 1999-2000 utilized . . 
the sum of moderate/vigorous LTPA with domestic PA minutes per week · · 
(min/wk) to create a three level PA variable (0 min/wk; < 150 min/wk; and � 150 
min/wk). PA participation at any level was not found to· be associated with the 
metabolic syndrome· (13). 
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These conflicting NHANES results that illustrate the relationship between 
PA and the metabolic syndrome might be related to the varying level of precision 
by which PA volume was measured or utilized by researchers. For example, in 
the three studies using NHANES I ll (8), duration was not collected in the PA self­
report interview, thus one of the three necessary components for �ccurately 
assessing PA volume was missing. Also, in the NHANES 1999-2000 study (1 3) ,  
the researchers elected not to use data on intensity linked to each specific 
activity which would have allowed MET·minutes per week to be calculated . . 
Utilizing data from the most recent NHANES, an opportunity ·now exists to 
more accurately measure L TPA volume and its relationship with the metabolic 
syndrome using a more comprehensive and precise measure of L TPA volume . 
. This measure, MET minutes per week (MET·min·wk-1) includes all the necessary 
components to precisely measure PA volume: frequency, intensity, and duration; 
With this in mind, the primary purpose of this study was to determine the 
relationship between L TPA volume and metabolic syndrome risk, and the 
secondary purpose of this study was to estimate the current prevalence of the 
metabolic syndrome in a nationally representative sample of the U.S. adult 
· population utilizing the most recent 1999-2004 NHANES. 
Methods 
This study utilized six years of data from the most recent 1999-2004 
NHANES, a continuous survey conducted by the National Center for Health 
Statistics (7). NHANES was designed to provide national estimates of the health 
129 
and nutritional status of noninstitutionalized U.S. civilians over the age of two 
months (7). 
Sample 
For the most recent six years of NHANES, the total· sample N is 31, 126, 
ages two months and above. For this study, the final sample consisted of 5,620 
U.S. adults � 20 years of age. The final sample met the following conditions: 1) · 
adult men and women � 20 years of age; 2) attended a morning medical 
examination center (MEC) examination following an overnight fast (minimum of 
eight hours); 3) if female, non-pregnant; and 4) had complete data on all the 
variables of interest. 
Measures 
· AHAINHLBI Metabolic syndrome definition 
The dependent variable in this study was a positive diagnosis of the 
metabolic syndrome based on the American Heart Association and National 
Heart, Lung, and Blood Institute (AHA/NHLBI) definition (15). The AHA/NHLBI 
definition requires that three of the following· five CV risk factors be present for a · 
diagnosis of the metabolic syndrome: 1) impaired fasting glucose ( IFG) � 100. 
milligrams per deciliter (mg/dL) or undergoing pharmacological treatment for IFG; 
2) low high-density lipoprotein cholesterol (HDL-C) (< 40 mg/dL in men or < 50 
mg/dL in women) or undergoing pharmacological treatment for an ·abnormal · 
HDL-C level; 3) triglycerides � 150 mg/dL or undergoing pharmacolog·ical 
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treatment for hypertriglyceridemia; 4) a waist circumference 0/VC) � 102 
centimeters in men or � 88 cm in women; and, 5) blood pressure � 130/85 
mm/Hg or undergoing pharmacological treatment for hypertension (HTN). The 
AHA/NHLBI definition is unique in the respect that it precludes specific inclusion 
criteria of any one condition found in all other medical society definitions-of th� 
metabolic syndrome (15). 
In creating a dependent variable based on a positive diagnosis of the 
metabolic syndrome utilizing the AHA/NHLBI definition, data on blood pressure, 
fasting glucose, l ipoprotein values, and WC measurements were utilized from the 
MEC, the health examination component of the NHANES. Each CV risk factor 
was dichotomized with the dem·arcation being the cut-off value or pharmalogical 
treatment for inclusion as a component of the metabolic syndrome (O= no risk; 1 = 
risk). Risk factors were summed and a total metabolic syndrome risk score 
(MSRS) was calculated which ranged from O (no risk factors) to five (all five risk 
factors present). Those subjects with a score of 0-2 risk factors were determined 
not to have the metabolic syndrome and those respondents with a score of 3 to 5 
risk factors were determined to have the metabolic syndrome. In this study, the . 
MSRS served as a secondary dependent measure utilized to examine the 
relationship of LTPA to the metabolic syndrome. 
Physical Activity 
Data utilized to measure LTPA was accessed from the .'physical activities 
individual activities file' (PAQIAF) (5) . The PAQIAF is. one of the two files · 
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measuring L TPA and includes more detailed information regarding 43-specific 
types of moderate and vigorous LTPA. The first measure, based upon LTPA 
MET-minutes per week, took the number of times an activity was done ·over the 
last 30 days and calculated an overall L TPA frequency per week. The 
compendium of PA (1) was used to assign an appropriate MET level to each type -
of activity performed. Then the average duration (minutes per session), was used 
in combination with the average frequency (number ·of sessions per week) and 
the intensity level (MET-level) to calculate the MET minutes per week 
(MET·min·wk-1) specific to each LTPA activity. With the sum of all L TPA 
METmin·wk·1 performed, we created a "Weekly L TPA MET·minutes" measure. 
In order to be able to examine a possible inverse association between 
L TPA and the metabolic syndrome, MET·min-wk-1 was divided into a six level 
ordinal variable. The first level represented those who reported performing no 
L TPA during the past month, the -referent group for this study. This level included 
all individuals who reported no moderate or vigorous L TP A. Thus, they received · . 
a score of "O" METmin·wk·1 . In calculating the remaining five levels of this 
measure, the METmin·wk·1 were divided into·quintiles from the MET-min·wk·1 : 
measure: 1st quintile >0.0-�156.24 MET·min-wk·1 ; 2nd quintile >156.24-�393.10 
· MET·min·wk·1 ; 3rd quintile >393.10-�736.55 MET·min·wk�1 ; 4th quintile > 736;55-
<1360.15 MET·min·wk·1 ; 5th quintile >1 360.15-MET·min·wk-1 • This was done to 
account for the non-normally distributed and skewed PA measures inherent in 
national population surveys (17). 
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A second L TPA measure used to examine the possible inverse 
association with the metabolic syndrome was a three-level categorical variable 
based on the CDC/ACSM PA public health recommendation (24). Individuals 
who met the CDC/ACSM PA recommendation of five days per week o_f moderate 
intensity PA fo� 30 minutes, or three days per week of vigorous intensity PA for 
20 minutes were classified as meeting the public health recommendation; 
individuals who engaged in LTPA at least one time per week at any duration or 
intensity but not meeting the CDC/ACSM recommendation were classified in the 
·_ - some, but insufficient category; and those who reported performing no L TPA 
were classified as inactive. 
Other Measures 
Other measures used in this research included demographic variables of . 
age and race/ethnicity, and two markers of socioeconomic status (SES), i.e: 
education and income. Education was categorized as completing less than 1 ih 
· grade, completing 1 ih grade, or education beyond 1 ih grade. Income was 
· categorized as a percent of the poverty threshold (< 100%, -100 to · 199%, 200 to 
299%, 300 to 399%, > 400%). The standardized poverty thresholds represent 
dollar amounts that define poverty status while accounting for family size (6). 
Falling below a poverty threshold of 100% demarcates living in poverty. I n  
addition, we used measures associated with alcohol consumption, smoking 




The data in this study were initially managed using SAS 9. 1 (26). SAS was · 
used to conduct both complex variable recodes and data coding validation� SAS­
callable SUDAAN (25) was then used to conduct the analysis, incorporating 
sampling weights within the context of the correlated multi�stage complex 
sampling design inherent to NHANES (4). Age-adjusted prevalence estimates· 
were calculated used PROC DESCRIPT for demographic characteristics and the 
additional covariates. For all prevalence estimates, non-overlapping 95% Cls will 
indicate significance. Logistic regression (PROC RLOGIST) analysis was used to -
estimate odds ratios (OR) and 95% confidence intervals (Cl) for the metabolic 
syndrome (dependent variable (DV)) and both measures of LTPA. Multiple 
logistic regression (PROC MULTILOG) was then used to estimate the OR and 
95% Cl of accumulating additional CV risk factors using the metabolic syndrome 
risk score as the DV with both measures of LTPA. 
Results 
Metabolic syndrome prevalence 
Applying the AHA/NHLBI definition, the overall age-adjusted prevalence of 
the metabolic syndrome among the U.S. adult population was 36.3%; anq the 
prevalence was similar for men 36.9% (95% Cl 34.4%-39.4%) and women 35.6% 
(95% Cl 33.2%-38.0%) (See Table 1 ). The prevalence of the metabolic . 
syndrome increased with age; 14.9% among those aged 20-29 years and 60.0% . · 
among those 70-79 years of age. Specific to· race/ethnicity, Non-Hispanic Blacks 
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Table 1. Metabolic Syndrome Prevalence According to the AHA/NHLBI Criteria 
by Demographic Characteristics and Other Lifestyle-Related CV Risk Factors 
Among U .S .  Adults >20 Years - NHANES 1999-2004. 
Age-adjusted 
Sample Weighted prevalence. 
N Ratio % 95% CI 
5620 36.3 34.5, 38. 1 
Gender 
Male 2837 49.3 36.9 34.4. �9.4 
Female 2783 50.7 35.6 33.2, 38.0 
Age 
20-29 871 1 7.9 1 4.9 1 1 .6. 1 8 .2 
30-39 91 7 2 1 . 1  23.5 20.4, 26.5 
40-49 1 007 22.0 34.8 30. 1 ,  38.7 
50-59 763 1 6.7 48.7 44.6, 52.9 
60-69 949 1 1 .2 59.6 56.3. 63.0 
70-79 645 7 .3 60.0 54.7, 65.3 
�80 468 3.8 48.3  42.7, 54.0 
Race/Ethnicity 
Non-Hispanic White 2934 72.0 36.7 34.3. 39.2 
Non-Hispanic Black 1 016  1 0.6 30.8 27.9, 33.7 
Mexican-American 1291 7.2 41 .2 37.9, 44.4 
Other 379 9.2 37.3 31 .5, 43.0 
Education 
<High school 1 792 20.3 40.3 37.0, 43.6 
High school 1 302 26.0 40.9 37.2, 44.7 
>High school 251 5 53.7  32.6 29.9, 35.4 
Income (%poverty level) 
<O - <1 00 874 1 2 .8 · 38 .5 33.9, 43.2 
�1 00 - <200 1 342 2 1 .2 38.9  35.3, 42.7 
�200 - <300 846 1 5.7 37.9 33.2, 42.5  
�300 - <400 628 1 3.8 37.6 32.6, 42.7 
�400 1 470 36.5  33.4 . 30.4, 36.4 
Smoking 
Current smoker 1 239 24.4 35.4 32 .3, 38.5 
Previous smoker 1 552 26. 1  37. 1 33.5, 40.6 
Never smoked 2822 . 49.5 36.3 33.3, 39.4 
Alcohol 
Above moderation drinker 381 8 .3 3 1 . 5  27.2, 36.0 
Moderate drinker 3088 62.0 34.5  32 .3, 36.8  
Non-drinker 1 859 29.7 42 .4 38.9, 45 .9 
Family history of heart d isease 
Yes 449 6.8 51 .2 43.0, 59.4 
No 51 71 · 93.2 35.5 33�7, 37.4 
Family history of d iabetes 
Yes 451 5.7 . 52 .6 42.3, 63.0 
No 51 69 94.3  35.5 33.6, 37.3 
NHANES:c National Health and Nutrition Examination Survey. AHA/NHLBI= American Heart Association/National Heart, Lung, and Blood Institute. 
CV= Cardiovascular. Cl= Confidence Interval. 
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were found to have the lowest overall- prevalence of the metabolic syndrome 
(30.8%; 95% Cl 27.9, 33 .7) while Mexican-Americans were found to have the 
greatest prevalence (41 .2%;  95% Cl  37.9%, 44.4%) . I n  addition,  level of 
educational attainment, l ifestyle habits, and having fam ily h istory of heart d isease 
or diabetes were a lso associated with metabolic syndrome prevalence· in  U .S: 
adults (See Table 1 ) . 
Metabolic syndrome prevalence by L TPA MET·minutes and the CDC/ACSM 
recommendation 
Table 2 i l lustrates the prevalence of the metabolic syndrome among U .S .  
- adults by weekly L TPA M ET·minutes and according to the current CDC/ACSM 
publ ic health PA recommendation . When examin ing metabolic syndrome · -
prevalence by the L TPA qu inti les of weekly MET minutes found in Table 2 ,  there 
was an inverse relationship ·found between L TPA weekly MET·minutes and the 
prevalence of the metabol ic -syndrome. The lowest metabolic· syndrome 
prevalence (27.2%; 95%. Cl 22.7-3 1 .7) was found among those reporting the 
greatest volume of L TPA and was sign ificantly d ifferent than from those reporting 
no L TPA and those reporting weekly L TPA MET;minutes fal l ing within  the first 
three quintiles of activity (See Table 2). 
· When focusing on the CDC/ACSM publ ic health PA recommendation , a 
sign ificant d ifference was found·for m·etabolic syndrome- prevalence between 
those meeting the current public health PA recommendatiori ,  29.0% (95% Cl 
25.5-32 .6) and those reporting no LTPA,· ·40 .0% (95% Cl  37.5-42.6). The 
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Table 2. Metabolic Syndrome _Prevalence by Weekly L TPA and the CDC/ACSM 
Public Health PA Recommendationt Among U.S. Adults �20 Years - NHANES 
1 999-2004. 
Weekly L TPA MET minutes 
0.0 
>0.0 - �1 56 .24 
> 1 56.24 - �393. 1 0  
>393. 1 0  - �736.55 
>736.55 - �1 360. 1 5  
> 1 360. 1 5  
Weekly L TPA MET minutes 
Inactive 
Insufficiently active* 
















36.8, 45.7  
32.9, 4 1 .4 
31 .8, 40.8 
24.5, 34.6 
22.7, 3 1 .7  
95% CI 
37.5, 42.6 
35. 1 ,  40.0  
25.5, 32.6 
AHA/NHLBl=American Heart Association/National Heart, Lung, Blood Institute. 
CDC/ACSM=Centers for Disease Control and Prevention I American College of Sports Medicine. 
L TPA= Leisure-time physical activity; CV= Cardiovascular disease. PA=Physical activity. 
t Every US adult should accumulate 30 minutes or more of moderate-intensity physical activity on most, preferably 
all, days of the week and/or 20 minutes of vigorous physical activity on three days of the week (24). 
"'Physically active but insufficient to meet CDC/ACSM recommendation (24). 
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metabolic syndrome prevalences for those reporting some LTPA 37.6% (95°/c, CI 
35. 1-40.0) and no LTPA, 40.0% (95% Cl 37.5-42 .6) were foqnd to be quit�. 
similar (See Table 2). 
Metabolic syndrome and L TPA MET·minutes per week 
Table 3 illustrates the OR for a metabolic syndrome diagnosis and the OR 
for adding one additional CV risk factor inherent within the MSRS by L TPA 
weekly MET-minute volume. Adults who acquired between 736.55 and 1360. 15 
MET·min-wk-1 of L TPA were found to be 35% (OR 0.65; 95% Cl 0.48-0.88) less 
. likely to meet the AHA/NHLBI metabolic syndrome d iagnosis criteria compared to 
those reporting no LTPA; and those reporting >1360. 15 MET·min·wk·1 were 
found to be 45% (OR 0.55; 95% Cl 0.42-0.71) less likely to have the metabolic 
· syndrome compared to those reporting no LTPA (0 MET·min·wk·1) .  
When examining. the risk of increasing the metabolic syndrome risk score 
(MSRS), decreased CV risk was also found beginning at the fourth quintile of 
L TPA (See Table 3) . Adults who acquired between 736 .55 and 1360. 15 
MET·min·wk·1 of LTPA were found to be 3 1% (OR 0.69; 95% Cl 0.56-0.85) less . 
likely to accumu late one additional CV risk factor compared to those reporting no 
L TPA. Furthermore, those reporting >1360 .15 MET�min·wk-1 were found to be 
42% (OR 0.58; 95% Cl  0 .48-0.70) less likely to add an additional CV risk factor. 
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Table 3. Odds Ratios of Metabol ic Syndrome diagnosis and Increasing 
Metabolic Syndrome Risk Score (MSRS) by L TPA* Weekly METminutes ·­
NHANES 1 999-2004. 
Metabolic syndrome risk 
by L TPA level 
Risk of increasing 
MSRS 
Weekly LTPA MET minutes 
0.0 
=:,-0.0 - �1 56.24 
>1 56.24 - �393. 1 0  
>393. 1 0  - �736.55 
>736.55 - �1 360. 1 5  
>1360. 1 5  
Odds ratio 
1 .00 






0.94, 1 .4� 
0 .81 , 1 .23 
0.66, 1 . 1 2  
0.48, 0.88 
0.42, 0.71 











0.86, 1 .32 
0.79, 1 .20 
0.62, 1 .0 1  
0.56, 0.85 
0.48, 0.70 
·covariates adjusted for in the model include gender, age, race/ethnicity, education, income, smoking status, 
alcohol intake, family history of heart disease, and family history of diabetes. 






Metabolic syndrome and the CDC/ACSM public health PA recommendation 
Table 4 illustrates the OR of metabolic syndrom� diagnosis and. the· OR for 
adding one additional CV risk factor in the MSRS by the CDCIACSM public health PA . 
recommendation examining LTPA. Compared to those who reported being inactive (no 
L TPA), participants who reported a volume of L TPA meeting or exceeding_ the current. 
CDC/ACSM public health PA recommendation were found to be 39% (0.61;  95% 
Cl 0.48-0. 77) less likely to have the metabolic syndrome compared to those 
reporting no L TPA. When examining the risk of accumulating one additional CV 
risk factor (MSRS), those meeting or exceeding the ·current CDC/ACSM PA 
recommendation with L TPA were found to be 36% (OR 0.64; 95% Cl 0.53-0.77) 
less likely to accumulate an additional risk. 
· Note: Alternate findings from examining total PA from all three domains and· a 
brief discussion can be found in Appendix C . .  
. Discussi.on · 
With the most recent 1999-2004 NHANES data and the metabolic · 
syndrome definition proposed by the AHA/NHLBI (1 5), this study found that 
36.3% of the U.S. adult population can be classified as . having the metabolic 
syndrome. This study represents the first national prevalence estimate of the . .  
metabolic syndrome in the U.S. adult population usiog the AHA/NHLBI definition 
and is similar to metabolic syndrome prevalence estimates found by Ford (11) 
utilizing the International Diabetes Federation and World. Health Organization 
definitions in 1999-2002 NHANES; These findings also illustrated a strong 
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Table 4. Odds Ratios of Metabolic Syndrome diagnosis and Increasing Metabolic 
Syndrome Risk Score (MSRS) by CDC/ACSM publ ic health PA recommendation• 
{L TPA) -NHANES 1 999-2004 
Metabolic syndrome risk 
by L TPA level 




Insufficiently active t 
Meets PA recommendation• 














0.81, 1 .07 
0 .53, 0.77 
Covariates adjusted for in the model include gender, age, race/ethnicity, education ,  income, smoking status, 
alcohol intake, family history of heart disease, and family history of diabetes. 
CDC/ACSM=Centers for Disease Control and Prevention / American College of Sports Medicine. 
L TPA= Leisure-time physical activity; CV= Cardiovascular disease. 
· ·Every US adult should accumulate 30 minutes or more of moderate-intensity physical activity on most, preferably 
all, days of the week and/or 20 minutes of vigorous physical activity on three days of the week (24). 
t Physically active but insufficient to meet CDC/ACSM recommendation (24). 
14 1  
- p value 
for trend 
0:0001 
inverse association between L TPA and the metabolic syndrome. Beginning with 
a LTPA volume of 736.55 weekly MET·minutes, .adults that .met or surpassed .this 
level of LTPA were 35% lesslikely to be classified as t,aving the metabolic 
syndrome. A similar inverse association (OR 0.61; 95% 91 0.48-0.77) was 
observed when PA was coded to represent the CDC/ACSM public health PA 
recommendation. Furthermore, a similar inverse association (OR 0.64; 95% Cl 
0.53-0.77) 'for meeting the CDC/ACSM public health PA recommendation was 
found when examining the metabolic syndrome risk score (MSRS). It appears 
that in order to reduce the risk of the metabolic syndrome through L TPA, an adult 
needs, at a minimum, to meet the current CDC/ACSM public health PA 
recommendation (24 ). 
Our findings concur with previous epidemiological PA studies that have 
examined the relationship between PA and the metabolic syndrome utilizing the 
1988-1994 NHANES Ill (9, 28). Zhu et al. (28) found that men and women who 
reported the greatest volume of L TPA were 59% and 75%, respectively, less 
likely to have the metabolic syndrome. DuBose et al. (9) when examining the 
potential association between L TPA and metabolic syndrome, with the most 
active participants being the referent group, found that those adults who reported 
no L TPA were 45% more likely to have the metabolic syndrome. In the present 
study, the metabolic syndrome prevalence of 40.0 % in the inactive group 
translates into this group being 65% (OR 1.65; 95% Cl 1.31-2.08) more likely to· · 
. be classified with the metabolic syndrome when compared to those meeting the 
CDC/ACSM public health PA recommendation. · 
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Interestingly, in a study utilizing the most recent NHANES data, Ford et al. 
( 1 ,3), found no sig�ificant association between PA and th_e met�bolic syndrome. 
However, Ford et al. only utilized frequency and duration to measure PA in total 
minutes per week. The current study linked each specific L TPA with a specific 
MET level from the compendium of PA ( 1 )  to create a total MET-minut�s per 
' ' 
week, a more precise measure of L TPA volume. It appears that using this more 
precise measure of L TPA allows for a more accurate analysis of the association 
between L TPA and the metabolic syndrome. 
In further examining L TPA volume, as it relates' to the metabolic 
syndrome, the magnitude of the inverse association increased (OR 0.55; 95% Cl 
0.42-0.71) for adults who accrued > 1 360.15 weekly MET·minutes of LTPA. This 
volume of L TPA (i. e. 60 minutes per day of moderately intense PA) coincides 
with the AHA and ADA PA recommendation (1 6) for the clinical management of 
the metabolic syndrome. This additional benefit was not only observed for being 
diagnosed with the metabolic syndrome, but also when examining the odds of an 
increasing metabolic syndrome risk score (MSRS) that ranged from O (no risk) to 
5 (all five CV risk factors present). This recommended volume of L TPA may be · 
preferable by physicians and other health care professionals working with 
populations at risk for developing the metabolic syndrome. Greater volumes of 
L TPA may increase the likelihood that these populations will be-able to lose or 
maintain a healthy weight, thus reducing the risk of the metabolic syndrome. 
However, motivating people to become physically active is a difficult task an.d 
with the findings in this study suggesting the current CDC/ACSM public health 
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PA recommendation for health translate over to a possible reduction in the risk of 
the metabolic syndrome, recommending 30 n:,i�utes pe� day of moderate!y . 
intense PA may be prudent. 
To date, no randomized control trials (RCTs) examining the role of the 
. . . . ' 
CDC/ACSM public health PA recommendation with the prevention of the 
metabolic syndrome as the primary outcome have been conducted. The closest 
smaller prospective studies toward this end were conducted by Laaksnen et 
al.(21) and Ekelund et al. (10). Laaksnen et al. (21), in ·a prospective study found . 
that middle-aged men who met the current CDC/ACSM PA recommendation, 
through structured ·or other lifestyle PA, were half as likely to develop the . 
metabolic syndrome compared to men engaging in no more than 60 minutes of 
moderate exercise per week. In another prospective study, Ekelund et al. (10) 
reported that middle-aged men who had a physical activity energy expenditure . 
(PAEE) equivalent to one hour per day of brisk walking were found to have a 
significantly lower risk of developing the metabolic syndrome. Perhaps there is . 
enough evidence from this and other studies (2, 9, 10, 19) to warrant RCTs that 
focus on identifying the precise volume of PA that coincide with the current 
CDC/ACSM public health PA recommendation (24) and the PA recommendation 
issued by the AHA and ADA (16). 
One of the weaknesses of physical activity epidemiology studies related to 
the metabolic syndrome is the lack of a standardized measure. U nlike NHANES 
1 1 1 ,  the current NHANES assessed frequency, intensity, and duration of PA, thus 
allowing investigators to more precisely examine association between LTPA and 
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metabolic syndrome risk. Unfortunately, despite the precision of our L TPA 
measure of weekly MET·minutes, it is not possible to directly compare our 
findings to thc;,se from previous studies · (9 , 13, 28) examining PA and metabol ic 
syndrome risk in NHANES. 
Study limitations 
These findings must be interpreted in light of the potential l imitations. First, 
· the cross-sectional nature of the study design does not allow causality to be 
inferred. Second, recall bias was possible due to L TPA being assessed by a self­
report interview from a frame of reference of the previous 30 days. Third, LTPA, 
smoking, and alcohol·responses may have been subjected to the social 
desirability effect _ (i. e. providing answers to impress or please interviewer) . Lastly, 
dietary factors. (i. e. caloric intake) were not controlled due to the complex nature 
of this data inherent to 1999-2004 NHANES.  
Conclusion 
Our findings estimate one in three U.S. adults have a Metabolic Syndrome 
Risk Score (MSRS) classifying them as having the metabol ic syndrome. 
Metabolic syndrome risk and the risk associated with MSRS were found to be 
inversely associated with increasing LTPA volume. This is consistent with the 
majority of metabolic syndrome studies examin ing the association with PA (14) . 
In addition, the magnitude of the inverse association between LTPA and the 
metabolic syndrome becomes greater when LTPA volume increases. However, 
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longitudinal studies and RCTs using population-based methodology are needed 
to reaffirm this study and previous smaller prospective studies ·(3, 10, · 1 a-21 ). 
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The Metabolic Syndrome: How Definition Impacts Prevalence and Risk in 
U.S. Adults 
NHANES 1 999-2002 
1 53 
Abstract 
Purpose: To examine the relationships various definitions have on Mets 
prevalence and risk estimates among a national sample of adults. Methods : The 
.sample for this study-included adults, 20 years and older, (N=37 45) who 
completed the mobile examination center (MEC) examination jn the 1999-2002 
National Health and Nutrition Examination Survey (NHANES). SUDAAN 
statistical software was used to estimate age-adjusted prevalence and odds risk 
ratios. Results: The overall age-adjusted Mets prevalence ranged from a high of 
39.5% (ACE/AACE), to a low of 22.0% (WHO). For most Mets definitions, males, 
people in the seventh decade of life (60-69 years of age), Mexican-Americans, 
those without a high school education, and those living in poverty were found to 
have the greatest prevalence. Corresponding to prevalence estimates, females 
were 23% to 30% less likely to be diagnosed with the Mets. People in the 
· seventh decade of life, Mexican-Americans, those With less than a high school 
education and those .living in poverty were found to have the greatest risk for 
· being diagnosed with the Mets. Conclusion: Mets prevalence and risk 




The aggregation of multiple cardiovascular risk factors was first observed 
by Kylin early in the twentieth century (50) , when he reported a syndrome that 
included the clustering of hypertension (HTN), hyperglycemia, and 
hyperuricemia. Subsequently, Kylin's syndrome was expanded through the work 
by Vague (70) who proposed adding central adiposity and diabetes, and Avogaro 
(7) who added obesity, both of which strengthened the relationship between the 
clustering of risk factors and cardiovascular disease (CVD). In a landmark paper, 
Reaven (62) described a series of abnormalities called "Syndrome X" , which 
included insulin resistance (IR) , glucose intolerance, HTN , hyperinsulinemia, 
elevated very low-density lipoprotein (VLDL) triglycerides, and low high-density 
· lipoprotein cholesterol (HDL-C). This clustering of metabolic abnormalities, or the 
metabolic syndrome (MetS)·as it is most commonly known today, has had many 
labels over the past four decades, including special metabolic syndrome (47) , 
syndrome X (62) , the deadly quartet (48) , insulin resistance syndrome (43) , and 
the plurimetabolic syndrome (28). 
· This abundance of syndrome names is congruent-with the competing 
criteria for defining the Mets. These competing criteria and their associated 
prevalence estimates often lead to confusion for the clinician and researcher 
al ike (10). Previous Mets prevalence estimates in United States (U.S.) adults 
range from a low of 7% in persons aged 20-29 years to a high of 44% to those in 
the seventh decade of life (38). Mets prevalence has been shown to vary 
depending on which medical society definition is adopted (9) . To date, there is no 
155 
consensus for a definition between the five most commonly used medical society 
definitions that measure the Mets (See Table 1) .. Several investigators have 
attempted to identify the best working definition by comparing multiple definitions 
(9, 27, 30, 51, 71). However, only 11 studies h�ve been conducted utilizing 
national surveillance data (4, 6, 14, 16, 17 , 35-38, 42, 49). 
Cameron et al. (16), summarized two studies that have reported using a 
nationally representative sample (17, 3 1). Overall prevalence estimates from the 
Australian Diabetes, Obesity and Lifestyle Study (Aus Diab) (31) were reported to 
be 15.9% for the European Group for the Study of Insulin Resistance (EGIR) 
definition (8) , 18 .3% for the National Cholesterol Education Program (NCEP) 
definition (55), and 20.9% for the World Health Organization (WHO) definition 
(72). The other prevalence estimate in this review originated from a national 
sample of Mauritians in which prevalence estimates ranged from a high of 19. 1 % 
(WHO) to a low of 1 3.8% (NCEP) (17): 
Since the Mets has become a focal point of metabolic research, several 
researchers have used national representative samples in reporting prevalences 
- (4, 6, 14 , 35, 37, 39, 42, 49), but most investigators utilized only one definition. 
Ford (36, 37), using data from the National Health and Nutrition Examination 
Survey (NHANES) has taken .the lead in contrasting prevalences of the Mets 
.using various published definitions. Ford (2003) initially reported national 
prevalences of the Mets using the WHO (1999) and · the NCEP (2001 )  definitions. 
The age-adjusted prevalence of the Mets in U.S. adults � 20 years. in NHANES 
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-I. 
Table 1 .  Metabolic syndrome definitions from various medical societies. 
WHO 1999 EGIR _,999 
Requisite criteria IGT, IFG, Insulin in top 
type 2 diabetes, quartile of 
insulin in top quartile population 
of population 
Other Criteria Plus � 2  of: Plus � 2  of: 
Glucose N/A �1 00 mg/dl, 
2-hour post OGTT 
�1 40 mg/dl but 
not diabetes 
Obesity W:H ratio >0.9 Waist � 94 cm in 
in men or >0.85 men 
in women; BMI or �80 cm in women 
>30 
Lipids TG �1 50 mg/dl TG > 1 80 mg/dl 
ACE/AACE 2003 
High risk a; BMI 
>25 or waist 
>1 02 cm (men) 
or >88cm 
(women) 
Plus � 2  of: 
�1 00 mg/dl, 
2-hour post OGTT 
�140 mg/dl but 
not diabetes 
NIA 
TG >150 mg/dl 
IDF 2005 
Waist �94 cm (men) 
and �80 cm 
(women), 
population specific 
for ethnic groups b 
Plus � 2  of: 
�1 00 mgidL, 
diabetes 
NIA 
TG �1 50 mg/dl 
AHA/NHLBI 2005 
NIA 
� 3 of: 
�1 00 mg/dl, 
diabetes 
Waist �1 02 cm in 
men 
or �88 cm in women · 
TG �1 50 mg/dl or 
01 
CX) 
_Table 1 .  Metabolic syndrome definitions from various medical societies (continued}. 
and/or HDL-C and/ or or HDL-C <40 or Rx or HDL-C <40 HDL-C <40 mg/dl in 
<35 mg/dl in men HDL-C<39 mg/dl mg/dl in men mg/dl in men 
or <39 mg/dl in . in men or women or or <50 mg/dl in women or <50 mg/d/L in 
women RX women or Rx 
Hypertension �1 40/90 mm Hg 
or Rx 
�140/90 mm Hg 
or Rx · 
>1 30/85 mm Hg 
or Rx 




men or <50 
mg/dl in women or Rx 
�1 30/85 mm Hg 
or Rx 
WC, waist circumference; W:H, waist hip; TG, triglycerides; QGTT, oral glucose tolerance test; Rx. medication; ACR, albumin: creatinine · 
ratio; others designated in text. WHO=World Hea.lth Organization EGIR=European Group for the study of Insulin Resistance 
AHA/NHLBl=American Heart Association/National Heart, Lung, and Blood Institute ACE/AACE=American College of 
Endocrinology/American Association of Clinical Endocrinologists IDF=lnternational Diabetes Federation. 
. . . 
a Family h istory of type 2 or gestational diabetes,. known CVD, polycystic ovary syndrome, physically inactive lifestyle, >40 years of age, 
and ethnic populations at high risk for a type 2 diabetes. ·· 
b Mexrcan-A.merican men waist circumference cut-off point is � 90 cm. 
Ill was 25.1 % (WHO) and 23.9% (NCEP). In a follow-up study using data from 
the most recent NHANES 1999-2002, Ford (36) contrasted the NCEP and 
International Diabetes Federation (46) criteria for the Mets , reporting 
prevalences of 34 .6% and 39.1 %, respectively. 
To date, no one study has compared prevalence estimates of all five 
commonly used medical society definitions described in Table 1. This study 
examines the prevalence estimates for all of these defin itions using the NHANES 
(1999-2002) national database, thus extending the previous work of Ford by 
three definitions. In addition, risk profiles for being diagnosed with the Mets 
specific to each defin ition will be examined. 
Methods 
This study utilized data from NHANES,  a continuous survey conducted by 
the National Center for Health Statistics (21 ) .  In 1999, the National Center for 
Health Statistics (NCHS) began releasing public use data files continuously as 
smaller component-specific data files on an ann·ual basis. The most recent 
survey was conducted from 1999 through 2004 and ·represents the eighth series 
of surveys. These surveys were designed to provide national estimates of the 




The- 1999-2002 NHANES databases contain information on 21,004 
individuals over two months of age. Complete data assuring full fidelity for all five 
Mets definitions in this study was not released at the time of our analysis, 
therefore-only the first four years of data was utilized in our investigation. The 
sample for this study-included non-Hispanic White, non-Hispanic Black, Mexican-
American, and the Other race/ethnicity category, aged 20 years and older 
(N=9,688). Eligible participants for this study attended the mobile examination 
center (MEC) following an overnight fast (minimum·a hours) and received a 
clinical exam up. Women who reported being pregnant were excluded. Complete 
data, for the final sample in our study, included 3,745 adults. 
Measures 
The five demographic variables utilized in our analysis incJuded gender, 
age, race/ethnicity, and two markers of socioeconomic status (SES), i. e. 
education and income. Education was categorized as completing less than 12th 
· grade, completing 1 ih. grade, or education beyond 1 ih grade. Income was ·--. 
categorized as a percent .of the poverty threshold (< 100, 100 to 199, 200 to 299, · -
300 to 399, > 400). The. standardized poverty thresholds represent dollar 
amounts that define poverty status while accounting for family size (22). Falling 
below a poverty threshold of 100% demarcates living in poverty. 
The collection of blood and urine was performed in the MEC during the 
clinical examination. These samples were obtained in order to measure specific 
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variables, allowing researchers to examine risk profiles. The data utilized from 
blood samples in this study were fasting plasma insulin . values to verify meeting 
the top population quartile, demarcating IR, HDL-C and triglyceride values to . 
· classify dyslipidemia,· and blood glucose values in order to classify IFG. The data 
utilized from the urinanalyis was for the classification of microalbuminuria (high­
protein levels in the urine. Detailed specimen collection and processing 
· instructions are d iscussed in the NHANES Laboratory/Med ical Technologists 
Procedures Manual (LPM) (20). Three or four blood pressure (BP) readings- were 
taken in the MEC and the average was reported for analysis (60). In addition, 
participants were asked as part of the home interview process if they have ever 
been told by a doctor or health care professional that they had diabetes. 
Metabolic syndrome definitions 
This· study utilized five working medical society definitions proposed for the 
diagnosis of the Mets. Table 1 summarizes the various definitions published by 
the World Health Organization (WHO) (72), EGIR (8), American Heart 
Association (AHA) and the National Heart, Lung and Blood Institute (NHLBI) ·. 
definition (41) which refers to the updated NCEP . (2001) definition, the joint 
American College of Endocrinology (ACE) and American Association of Clinical 
Endocrinologists (AACE) consensus definition for epidemiological rese_arch (33), 
and the IDF (46). The ACE/AACE definition represents the official position of an 
· ACE/AACE task force appointed by the AACE president (33). To facilitate 
comparisons, all five definitions reflect the change adopted by Grundy. and others 
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(41, 46) put forth by the American Diabetes Association (1) for lowering the 
diagnosing of I FG, lowering the cut-point from 110 mg/dl0to 100 mg/dl. In 
addition, we considered the current use of antihypertensive medication an 
indication of high BP. 
The majority of research that has been done on the Mets involved the use 
of the NCEP, WHO, and EGIR definitions (See Table 1 ). The NCEP definition 
requires that three of the following five criteria be present for a diagnosis of the 
Mets: impaired fasting glucose ( IFG), low HDL-C, elevated triglycerides, an 
increased waist circumference (WC), or HTN�  The NCEP definition is unique in 
the respect that it precludes specific inclusion criteria of any one condition (e.g. 
I FG) in order for Mets to be diagnosed. The most -recent definition put forth by 
the AHA and NHLBI (41) mirrors the NCEP (55) definition with the following 
modifications: medication use for those with dyslipidemia, HTN, and I FG 
maintains the diagnosis, and the cut-off point for IFG was lowered from 110 
mg/dl to 100 mg/dl to reflect the recent changes put forth. by the American 
Diabetes Association (ADA) for IFG (1 ) .  
The W_HO definition includes at least one of the following requisite 
conditions: impaired glucose tolerance ( IGT) , I FG,  type 2 diabetes (T2D) , or 
insulin levels in the top quartile of the population plus two of the following: low 
HDL-C or elevated triglycerides, a waist/hip (W/H) ratio >0.9 for men or >0.85 for 
women or body mass index (BMI) > 30 kg/m2 , HTN, or microalbuminuria. The 
WHO definition recommends a hyperinsulinemic-euglycemic clamp technique 
and an oral glucose tolerance test be used for estimating IR. Because these 
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techniques were not employed in NHANES,  fasting insulin concentrations were 
utilized to estimate IR and IFG was utilized in place of IGT, which has been 
previously recommended by EGIR (8). The EGIR definition requires insulin in the . 
upper quartile plus two or more of the following: low HDL-C or elevated 
triglycerides, WC of �94 centimeters (cm) for men and �80 cm for women,  HTN , 
or IGT or IFG but not diabetes. The EGIR feels diabetes should be treated as a · 
separate entity (8) . A key factor in T2D is beta-cell function , as this diminishes, 
ability in estimating insulin sensitivity is abated (75) . 
In addition ,  the IDF and ACE/AACE definitions have beeri proposed. The 
ACE/AACE definition requires one of the following: an individual to be classified 
as high risk for IR, BMI >25 kg/m2 or WC of > 1 02cm in men or >88cm in women 
plus at least two of the following: IFG or IGT but not diabetes, low HDL-C, 
elevated triglycerides , or a diagnosis of HTN. The recent definition put forth by 
the · 10F mirrors the AHA/NHLBI criteria except for the WC cut-points being 
lowered and individuals taking medication(s) for hyperglycemia being included in 
the IFG or diabetes category (See Table 1 ) .  
Statistics 
SAS (65) was used to recode the variables of interest, and SUDAAN (63) 
was used to conduct the analysis: SUDAAN incorporates sampling weights within 
the context of the complex sampling design inherent to NHANES (21 ). Age­
adjusted prevalences for the Mets we·re computed using PROC DESCRIPT with 
the direct method based on the 2000 U .S. ·population. Logistic regression ·using · 
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PROC RLOGIST was used to estimate odds risk-ratios for being diagnosed with -
the Mets (Mets yes versus Mets no). With logistic regression we controUed for 
gender, age, race/ethnicity, education, and income. 
Results 
Figure 1 displays two distinct phases of the Mets diagnosis process. 
Phase 1 reflects the proportion of the US adult population who meet the requisite 
condition(s) for each of the medical society definitions found in Table 1. The 
requisite condition prevalences range from 27% (EGIR) to the entire eligible 
sample (AHA/NHLBI). Subjects who met the requisite condition specific to each 
definition were then subjected to the phase two diagnostic criteria indicative of 
the Mets diagnosis. Figure 1, phase two, presents the Mets prevalence specific·· 
to each of the five medical society definitions. The two med ical society definitions 
resulting in the lowest prevalence rates (EG IR, 22.7%;  and-WHO� 22.0%) were 
found to have the lowest eligible pools for Mets diagno·sis. Approximately half of 
those meeting the requisite criteria for WHO were found to have the Mets, while 
more than 80% of those identified with the requisite condition for EGIR met the 
diagnostic criteria for the Mets. The IDF and ACE/AACE definitions were 
associated with the .highest prevalence rates (39.5% and 39. 1 % respectively). 
Similar to the WHO definition, the ACE/AACE and IDF prevalence estimates are 
approximately half of their respective eligible pools (See Figure 1 ). The 
AHA/NHLBI definition, which allows more flexibility, requires no requisite 
condition(s) and classifies one out of every three U.S. adults· as having the Mets. 
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WHO EGIR ACE/AACE IDF AHA/NH LB I 
Medical Society Definition 
1 Requisite criteria prevalence specific to medical society definition 
2 Mets prevalence for each medical society definition 
Figure 1 .  Prevalence of the Mets in US adults by diagnostic phase specific 
to medical society definition. 
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The overall age-adjusted and demographic-specific Mets prevalences 
across the various Mets definitions are shown in Table 2. The overall age- · 
adjusted Mets prevalence was highest (39.5%) within the ACE/AAC� definition, 
while the lowest overall prevalence (22·.0%) was found in the WHO definition. In 
. two of the five definitions, males were found to have greater prevalences than 
females. The exception was found with the AHA/NHLBI definition, where gender­
related prevalences were identical. The greatest difference between male and 
female Mets prevalence was found within the ACE/AACE definition with m�les at 
42.7% and females at 36.0%. Prevalences varied for gender between definitions, 
ranging from a low of 19.9% (EGIR) to a high of 36.8% (IDF) in females, and a 
low of 22.6% (WHO) to a high of 42.7% (ACE/AACE) in males. 
Specific to age, delineated by 10-year age groups, there was a consistent 
increase in Mets prevalence through the seventh decade (60-69 years of age) of 
life. Mets prevalence begins to decline or level off in the eighth decade (70-79. 
years of age) of life; this is consistent across the various definitions except 
ACE/AACE, where the drop in prevalence is not seen until the ninth decade �-ao 
years of age); Across definitions, Mets prevalence values ranged from a low of 
9.4%, (WHO) in the 20-29 year old age group, to a high of 60.3%, (ACE/AACE) 
in the 70-79 year old age group. 
MetS·prevalences specific to race/ethnicity, found Mexican-Americans to 
have the highest overall age-adjusted prevalence across all definitions, with the 
greatest prevalence rate being associated with the ACE/AACE defin.ition at 
- 48�5%. The lowest race/ethnic prevalence rates were associated with non-
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Table 2. Metabolic Syndrome prevalence specific to medical society defin itions by demographic characteristics 
among U.S adults aged ?. 20 years, NHANES 1 999-2002. 
WH01111 EGIR1911 ACE/AACE2003 IDF2oos AHA/NHLB12005 
N %• 95% Cit %• 95% Cit %• 95% Cit %• 95% Cit %• 95% Cit 
Total Age-Adjusted Prevalence 3745 22.0 (20.3, 23.8) 22.7 (20.7, 24.6) 39.5 (37.2, 41 .8) 39. 1 (37.4, 40. 1 ) · 36. 1  (34.3, 37.8) 
Gender 
Male 1 893 








> 80 292 
. Race/Ethnicity 
Non-Hispanic White 1 898 
22.6 (1 9.8, 25.3) 25.5 (22.7, 28.3) 42.7 (39.0, 46.4) 41 .2 (38.3, 44. 1 )  
21 .4 ( 1 9.2, 23.5) 1 9.9 ( 1 7.4, 22.3) 36.0 (34.0, 38.0) 36.8 (34.6, 39.0) 
9.4 (5.8, 1 3.0) 1 2.3 (8.7, 1 5.9) 20.3 (1 6.3, 24.3) 1 8.5 ( 14.4, 22.6) 
36.3 (33.3, 39.3) 
35.6 (33.2, 37.9) 
14.2 (1 0.4, 1 8.0) 
14.8 (1 2.0, 1 7.6) 1 9.3 (1 6.2, 22.4) 26.2 (22.9, 29.6) 24.7 (21 .3, 28. 1 )  23.9 (20. 1 ,  27.7) 
20.6 (1 5.9, 25.3) 25.0 (20.2, 29.9) 40.4 (34.4, 46.4) 38. 7 (33.3, 44. 1 )  35.4 (30.5, 40.3) 
28.0 (22.5, 33.4) 27.4 (21 .5, 33.3) 50.3 (44.4, 56.2) 51 .9 (47.2, 56. 5) 47.3 (43.5, 51 .2) 
37.6 (32.2, 43.0) 34.8 (30.3, 39.3) 57.7 (52. 1 ,  63.3) 63.2 (59. 1 ,  67.2) 
35.6 (30.5, 40.8) 23.9 ( 1 9.3, 28.4) 60.3 (54:0, 66. 7) 60. 1 (54. 7, 67.0) 
59.0 (55.3, 62. 7) 
58.7 (52�8. 64.7) 
31 .5 (24.2, 38.9) 1 9.5 ( 1 2.3, 26.6) 57.6 (51 .4, ,63.8) 50.9 (43.6, 58.2) 49A (42.7, 56.0) 
21 .7 ( 1 9.6, 23.9) 21 .8 ( 1 9.4, 24.2) 38.9 (35.6, 41 .9) 38.9 (36.6,, 41 . 1 )  35.7 (33.5, 37.8) 
-I. 
Table 2. Metabolic Syndrome prevalence specific to medical society definitions by demographic characteristics 
among U .S adults aged � 20 years, NHANES 1 999-2002 (continued).  
Non-Hispanic Black 663 
Mexican-American 916  
Other 268 
Education 
< High school 1 251 
H igh school 839 
> High school 1647 
Income {% of poverty level) 
< 0 -<1 00 579 
�1 00 -<200 851 · 
�200 -<300 544 
�300 -<400 41 9 
�400 999 
23.8 (20.2, 27.3) 
27.9 (24.7, 31 .0) 
1 9.9 (1 6.0, 23.8) 
24.0 (21 .2, 26.7) 
25. 1 (2 1 .3, 29.0) 
1 9.8 (1 7. 1 ,  22.6) 
25.4 (21 .3, 29.4) 
24.3 (20. 1 ,  28.4) 
23.8 (1 8.2, 29.5) 
22.4 (1 6.9, 28.0) 
1 9. 1  ( 16. 1 ,  22. 1 )  
24.8 (2 1 .7, 27.9) 
30.3 (27.8, 32.8) 
22.6 (1 7.0, 28. 1 )  
26.2 (22.5, 29.9) 
24.4 (1 9.5, 29.4) 
20.4 (1 7.5, 23.4) 
26.8 (22.7, 30.8) 
24.3 (20.3, 28.4) 
. 
I 
21 .0 ( 14.9, 27.2) 
21 .7 ( 1 5.7, 27.7) 
2 1 .2 ( 1 8.2, 24. 1 )  
3 1 .4 (27.7, 35.2) 33.2 (29.6, 36.8) 31 .5 (27.7, 35.3) 
48.5 (45.4, 51 .6) 48.4 (45.3, 51 .5) 42. 7 (39.4, 46. 1 )  
44.5 (36.5, 52.5) 41 .9 (37.0, 46.9) 40.9 (34.7, 47.2) 
46.3 (42.2, 50.3) 45.8 (41 .9, 49.8) 42. 1 (37.6, 46.6) 
43. 1 (37.9, 48.3) 42.8 (38. 1 ,  47.6) 41 . 1  (36. 1 ,  46.0) 
35.3 (32.4, 38.3) 34.9 (32.3, 37.5) 31 .3 (28.7, 33.9) 
45.2 (38.6, 5 1 . 8) 40.3 (35.0, 45.6) 40.8 (34.0, 47. 7) 
4 1 .3 (37.0, 45.7) 42.7 (38.4, 47.0) 38.4 (33.5, 43.3) 
40.6 (34.3, 46.9) 37.2 (31 .4, 43,.0) 37.6 (31 .2,  44.0) 
42.3 (36.0, 48.5) 41 .8  (35.3, 48.4) 39.4 (32.5, 46.3) 
35.0 (31 .4, 38.5) 36.5 (34.0, 39.0) 31 .6 (28.9, 34.3) 
•Percent prevalence. t95 percent confidence interval. WHO=World Health ·Organization· EGIR=European Group for the st�dy of Insulin 
. Resistance AHA/NHLBl=American Heart Association/National Heart, Lung, and Blood Institute ACE/AACE=American Coilege of 
· Endocrinology/American Association of Clinical Endocrinologists IDF=lnternational Diabetes Federation .  
: 
. . 
Hispanic Blacks in three out of the five definitions (AHA/NHLBI, ACE/AACE, and 
IDF) . Non-Hispanic Whites had the lowest prevalence rate (21.8%) according to 
the EGIR definition, and the "other'' race/ethnicity category had the lowest 
prevalence (19 .9%) specific to the WHO definition. 
A focus on educational attainment found that the lowest Mets prevalence, 
across all five medical society definitions, occurred in the group with the highest 
level of educational attainment (> high school) . For four of the five definitions, the 
. . . 
highest Mets prevalences were found in those who did not complete high school. 
In addition, Table 2 shows while there is no consistent trend either between or 
within definitions as reflected by poverty levels, those people below the 1 00% 
poverty threshold for four of the five definitions were found to have the highest 
prevalence-of the Mets. 
After controlling for gender (not stratified by gender) , age, race/ethnicity, 
education, and poverty level in multivariate logistic regression, several consistent 
risk factors were identified across the definitions (See Table 3) . For three of the 
five definitions, females were found to have a decreased likelihood of being 
diagnosed with the Mets. This reduced risk for females ranged from 2_3% to 30%. 
These findings closely mirrored the difference in prevalences between males and 
females found in Table 2. 
After controlling for all other factors, our data indicate the risk of being 
diagnosed with the Mets to be highly age-dependent, with risk increasing each 
decade through the seventh decade of life. For four of the five definitions, people 
in the seventh decade of life (60-69 years of age) were four to eight times more 
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Table 3. Odds ratios for being diagnosed with the metabolic syndrome specific to medical society definitions: U.S adults 
aged � 20 years, NHANES 1999-2002. 
WHO,n9 EGIR,999 
Independent variables and 
effects Adjusted Adjusted 
Odds ratio 95% Odds ratio 95% 
Cit Cit 
Gender 
Male• 1 .00 1 .00 
Female 0.93 (0.75, 1 . 1 5) 0. 70 (0.56, 0.87) 
Age 
20-29• 1 .00 1 .00 . 
30-39 1 .78 (1 .08, 2.91 ) 1 .79 (1 .22, 2.64) 
40-49 2.72 (1 .53, 4.83) 2.55 (1 .77, 3.69) 
50-59 4.42 (2.59, 7.56) 3. 1 3  ( 1 .98, 4.93) 
60-69 6. 1 9  (3.96, 9.68) 4.03 (2.76, 5.87) 
70-79 5.53 (3.05, 2.42 (1 .41 , 4. 1 5) 
1 0.03) 
> 80 4.88 (2.56, 9.32) 2.00 (0.97, 4. 14) 
ACE/AACE2uu3 
. Adjusted 
Odds ratio 95% 
Cit 
1 .00 
0.70 (0.59, 0.83) 
1 .00 
1 .50 (1 .08, 2.08) 
3.09 (2.02, 4.74) 
4.82 (3.32, 7.00) 
5.96 (4. 1 6, 8.53) 
6.43 . (4. 1 1 ,  1 0.05) 
6.06 . (3.83, 9.58) 
1DF2005 
Adjusted 
Odds ratio 95% 
Cit 
1 .00 
0.77 (0.64, 0.93) 
1 .00 
1 .51 (1 .05, 2. 1 9) 
3.26 (2. 1 4, 4. 97) 
5.66 (4.07, 7.88) 
8.45 (6.25, 1 1 .41)  
8. 1 0 · (5. 12 , 1 2.79) 
5. 75 (3.80, 8. 72) 
AHA/NHLBl2005 
Adjusted 
Odds ratio 95% 
Cit 
1 .00 
0.94 (0.77, 1 . 14) 
1 .00 
1 .94 (1 .27, 2.97) 
3.69 (2.46, 5.52) 
6.56 (4.59, 9.39) 
8.93 (6. 1 0, 1 3.05) 
8.95 (5.68, 14. 1 0) 
5;90 (3.85, 9.05) 
-.Ji. 
Table 3. Odds ratios for being d iagnosed with the metabolic syndrome specific to medical society defin itions: U .S adu lts 
aged � 20 years, NHANES 1 999-2002 (continued).  
Race/Ethnicity 
Non-Hispanic White• 1 .00 1 .00 1 .00 1 .00 1 .00 
Non-Hispanic Black 1 .09 (0.83, 1 .45} 1 .09 (0.84, 1 .42} 0.67 (0.52, 0.85} 0. 71 (0.55, 0.93} 0. 74 (0.57, 0.97} 
Mexican-American 1 .31 (0.94, 1 .84} 1 .44 (1 .08, 1 . 92} 1 .34 (1 .03, 1 .74} 1 .35 (1 .04, 1 .76} 1 . 1 7  (0.86, 1 .58} 
Other 0.81 (0.58, 1 . 1 3} 0.99 (0.69, 1 .44} 1 .26 (0.87, 1 .82} 1 . 1 5  (0.86, 1 .54} 1 . 1 5 (0.83, 1 .57} 
Education 
< H igh school• 1 .00 1 .00 1 .00 1 .00 1 .00 
High school 1 . 1 3  (0.8 1 ,  1 .56} 1 .01 (0.66, 1 .55} 0.96 (0.72, 1 .27} 0.89 (0.64, 1 .24} 1 .02 (0. 72, 1 .43} 
> High school 0.92 (0.69, 1 .2 1 }  0.86 (0.6 1 , 1 .2 1 }  0.69 (0.48, 0.99} 0.64 . (0.47, 0.88} 0.67 (0.48, 0.92} 
Income (% of poverty level) 
< 0 -<1 00• 1 .00 1 .00 1 .00 1 .00 1 .00 
�1 00 -<200 0.90 (0.68, 1 .20} 0.87 (0.64, 1 . 1 8} 0.83 (0.58, 1 . 1 9} 1 .03 (0.72, 1 .47} 0.88 (0.59, 1 .31 }  
�200 -<300 0.88 (0.62, 1 .26} 0.67 (0.43, 1 .05} 0.85 (0.59, 1 .24} 0.81 · co.61 ,  1 .23r o.a8 co.58, 1 .33} 
�300 -<400 0.80 (0.51 , 1 .23} 0.70 (0.44, 1 .09} 0.93 (0.64, 1 .33} 1 .02 (0.72, 1 .46} 0.98 (0.66, 1 .45} 
�400 0.65 (0.47, 0.89} 0.70 (0.50, 0.96} 0. 70 (0.48, 1 .02} o.84 co:62. 1 . 1 3} 0.70 (0.48, 1 .02} 
•Referent group. t95 percent confidence interval. WHO=World Health Organization EGIR=European Group for the study of Insulin · 
·. Resis�ance AHA/NHLBl=American Heart Association/National Heart, Lung, and Blood Institute ACE/AACE=American College of 
Endocrinology/American Association ·of Clinical Endocrinologists IDF=lnternational Diabetes Federation. 
likely to be diagnosed with the Mets compared to adults in the third decade of life 
(See Table 3). 
According to three of the five definitions, Mexican-Americans had the · 
greatest ri.sk for being diagnosed with the Mets compared to non-:-Hispanic 
Whites. This increased risk ranged from 34% (ACE/AACE) to 44% (EGIR). 
Conversely, a significantly lower risk for being diagnosed with the Mets was 
noted for non-Hispanic Blacks in three of the five definitions. Non-Hispanic 
Blacks were 29% to 33% less likely to be diagnosed with the Mets compared to 
their non-Hispanic Whites counterparts (See Table 3). 
For three of the five definitions (AHA/NHLBI , ACE/AACE, and I DF), Mets 
risk was significantly lower in people with greater than a high school education. 
After controlling for other factors, adults with this level of education were found to 
have a 31 % to 36% reduction in risk of being diagnosed with the Mets. In 
addition, reduced risk ranging from 30% to 35% was found among adults in the � 
400% poverty category, compared to those below the 100% poverty demarcation 
(See Table 3). This risk reduction was only found in this most affluent group 
within the WHO and EGI R  definitions. 
Discussion 
To date, nationally representative Mets prevalence studies in the U.S. 
comparing prevalences across definitions have only simultaneously employed a 
maximum of two definitions (36, 37). Our study extends this earlier research by 
simultaneously comparing the Mets prevalences for all five medical society 
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definitions using a nationally representative sample of the U.S. adult population 
within 1999-2002 NHANES. 
When examining the trends seen across the five working medical society 
definitions, there appears to be two levels of prevalence - low (WHO and EGIR) , 
and high (ACE/AACE, IDF and AHA/NHLBI). The lower prevalence estimates 
found with the WHO and EGIR definitions appear to be due to. the restrictive 
nature of the requisite criteria (See Table 1 ) .  The eligible pools for each definition 
as defined by the percentage of people .from our background population meeting 
the requisite criteria are displayed in Figure 1. When examining the four 
definitions with requisite criteria, the WHO, ACE/AACE and IDF definitions 
estimate prevalence to be approximately half of their eligible pool. However, the 
EGIR definition captures 84% of its eligible pool, thus suggesting insulin 
resistance and/or hyperinsulinemia may be a more sensitive filter for Mets than 
othe·r criteria. 
1 
Previous research examining prevalence estimates of the Mets 
and the individual components defining the syndrome has found there to be a 
strong link between insulin resistance and hyperinsulinemia with the clustering of 
risk factors that designate the Mets (26, 34, 43, 48, 61, 62, 74). 
Excluding the AHA/NHLBI crrteria, for which a requisite condition is not 
applicable, the specific requisite condition prevalence (phase 1) appears to serve 
as a filter in the remaining definitions, thus impacting the risk pool eligible for 
Mets diagnosis based on other criteria specific to each definition (See Figure 1) . 
In addition to the restrictive requisition criteria found in these low prevalence 
definitions, additional restrictions are imposed through HTN and triglycerides: 
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The moderate-level prevalence estimate of Mets associated with the 
AHA/NHLBI definition is likely due to the liberal nature of the definition in that no 
requirements or requisite conditions are imposed. In the absence of requisite 
criteria within the AHA/NH LB I definition, any combination of three of the five 
defining criteria for Mets diagnosis is plausible. The reason for this approach in . 
defining the Mets was that the AHA/NHLBI definition was developed to enable 
the clinician to easily ascertain values and make a Mets diagnosis in the office. 
The more recently developed IDF definition mirrors the AHA/NHLBI definition in 
order to maintain clinical utility. However, since the lower WC cut-off points 
demarcating obesity found in the IDF definition are a requisite condition, this 
directly impacts Mets prevalence (36). 
The high-level prevalence estimates were observed for the ACE/AACE 
and IDF definitions. A plausible reason for this is that requisite criteria of the 
ACE/AACE and IDF are related to a high-level estimate of prevalence (phase 1) 
. -
and their focus emphasizing BMI or WC. With 66.3% of the US adult population 
estimated to be overweight or obese (57), the eligibility pools for either of these 
two definitions is quite large. A closer examination of body size .the obesity 
requisite criteria identifies three possible reasons for the large eligibility pools . 
. First, the requisite criterion for the ACE/AACE definition includes a BMI ·> 25 
kg/m2 , thus capturing those who are both overweight and obese. Second, the 
ACE/AACE requisite criteria classify everyone > 40 years of age a high-risk. A 
closer look at Table 2 illustrates this would include two-thirds of the ·U .S. 
population. And thirdly, the IDF requisite criterion for WC is ethnic specific, which 
1 74 
not only enlarges the eligibility pool, but al lows for more accurate, ethnical ly 
sensitive prevalence· estimates. Until recently, epidemiological research utilized 
National Institutes of Health (NIH) WC -cut-off points for all ethnic groups in the 
US (56). Ethnic-specific WC cut-off points (which are often lower) are now 
recommended due to the fact recent research has ·shown the co-morbidities 
associated with body size or central obesity vary among populations (46, 75). 
Mets and gender 
When focusing on demographic Mets prevalence estimates, males were 
found to have a greater overall prevalence in two of the five working definitions. 
Males were also found to have a greater overal l  prevalence of -the Mets in 
NHANES Il l (37) . One explanation for this may be the higher prevalences of HTN 
and hypertriglyceridemia found in males in NHANES I l l .  Furthermore, in the 
CARDIA study (18) , a prospective study examining demographic characteristics 
and modifiable cardiovascular risk profiles with the likelihood . of developing the 
Mets in adult males and females, males were found to be .two to four times more 
likely to have the Mets without abdominal adiposity, thus suggesting the 
remaining Mets risk factors may cluster more i_n males. 
The lower prevalence estimates found among females in two of the five 
definitions correspond to our findings of females being 23% to 30% less_ likely to 
be diagnosed with the Mets. In NHANES 1 1 1 ,  Tong et al . (68) found men aged 35-
54 years to be more then twice as likely (OR 2.22, 95% -CI, 1.03-4.81 )  to have 
the Mets when compared to women in the same age category. (OR ·1:.05, 95% C l ,  
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0.40-2. 79). The transition from pre-to postmenopause is accompanied by many . 
characteristics defining the Mets, including increases in central adiposity, 
increases in both glucose and insulin levels, and often a shift to a more 
atherogenic lipid profile (19). The decreased risk of being diagnosed with the 
Mets found in our study may be explained by the protective effects of 
endogenous estrogen found in pre-menopausal females (69), however, this is 
still an unanswered question (68). 
Nevertheless, the clustering of cardiovascular risk factors is prevalent in both 
· males and females anct leads to an increase in CVD risk in both genders (73). 
Mets and age 
There is a strong positive association between the prevalence of the Mets 
and age. Our study found males and females 60-69 years of age to be four to 
eight times m?re likely to be diagnosed with Mets than. those 20-29 years of age. 
Males and females age 35-64in NHANES Il l  were found to be two to three times 
more likely to be diagnosed with the Mets than those age 20-34 (59). This likely 
occurs because of the increase in Mets risk factors (e.g: insu�in resistance,· 
obesity) that accompanies the normal aging process (13, 33). 
Mets and ethnicity 
Specific to race/ethnicity, Mexican-Americans were found to have the 
highest prevalence estimates and risk of the Mets across all five medical society · 
definitions. Mexican-Americans have been found to have greater prevalences of 
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abdominal obesity and hypertriglyceridemia (38) , and greater prevalences of 
fasting hyperglycemia (25) , compared to their non-Hispanic black and non- . 
H ispanic white counterparts. All of these conditions represent either requ isite 
(phase 1) or threshold (phase 2) conditions for Mets diagnosis. Additionally, _the 
clustering of cardiovascular risk factors associated with the Mets has been found 
to be more common in Mexican-Americans (25, 38, 59) , thus leading to the 
higher prevalence rates found in this population. 
Conversely, non-Hispanic blacks were found to have the lowest Mets 
prevalence estimates and risk in three of the five medical society definitions (See 
Tables 2 and 3) . The differences in metabolic alterations associated with central 
obesity may hold some the explanation for this racial disparity found between -
racial/ethnic groups. Despres (29) found blacks to have higher H DL-C levels and 
a more cardioprotective lipoprotein profile for similar levels of abdominal 
adiposity compared to whites. In NHANES Ill ,  non-Hispanic blacks were found to 
have a lower prevalence of dyslipidemia than their non-Hispanic white and 
Hispanic counterparts (58). This may be one reason non-Hispanic blacks were 
found to have lower overall Mets prevalences in three of the five definitions. This 
metabolic protection carried-by non-Hispanic blacks has been shown· to be the 
result of carrying lower amounts of visceral fat for the same level of adiposity 
compared to other populations (24, 45). 
The. non-Hispanic white (EGIR) and other racial/ethnic (WHO) category 
are found to have the lowest prevalence estimates when HTN diagnostic criteria 
are raised from 1 30/85 nimHg to 1 40/90 ·mmHg in the WHO and EGIR definitions 
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(See Table 2). This was not surprising knowing that non-Hispanic blacks have 
greater prevalences of HTN (44, 58, 66). Interestingly, approximately 50% of 
people with essential HTN have been found to be insulin resistant and· 
hyperinsulinemic (61). Insulin resistance has been postulated by many to be the 
core component of the Mets (2, 3, 5, 11,· 32 ; 34, 40, 62, 67). The coexistence of 
insulin resistance and HTN would identify approximately half of the eligibility 
pools for the WHO and EGIR definitions as being one condition away from Mets 
diagnosis, thus greatly increasing the likelihood of diagnosis in a smaller at risk 
eligibility pool. This relationship between insulin resistance and HTN warrants 
continued investigation. 
MetS and SES 
Socioeconomic status is a well established marker commonly used by 
epidemiologists (52). Outside of gender and race/ethnic background which are 
genetically determined, in this study environmental and societal markers of 
affluence were found to have the greatest relationship with risk and prevalence of 
the Mets. Our study utilized the two most common surrogates of SES, education 
and income. The relationship between SES and the core components of the . 
Mets has been previously examined (12, 15, 23, 53, 54). In NHANES 1 1 1 , Loucks 
et al. (54) found socioeconomic position (SEP) to be associated with the Mets. in 
non-Hispanic whites, ·non-Hispanic blacks, and Mexican-Americans, with the 
association being greater in women. People with diabetes from a low SES have 
been found to be at a greater risk for developing the Mets because they are 
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more likely to be obese and hypertensive (23). Brunner et al. (15) found central 
obesity, triglycerides, and high waist to hip ratios to be inversely associated with 
SES. Additionally, in a landmark paper by Rose and Marmot (64) looking at risk 
factors for CVD, overweight, obesity, and HTN, all conditions contributi.ng to a 
diagnosis of the Mets across all five medical society definitions, were reported to 
be associated with a lower SES. 
Study limitations 
Our findings must be interpreted in light of the potential limitations. Among 
the total number of criteria identified in all five definitions of the Mets, we were 
unable to measure four criteria due to them not being available in the most recent 
NHANES. First, oral glucose tolerance test (OGTT) values were not available. · 
We utilized three markers of insulin resistance or diabetes included in the WHO 
definition. These included IFG, T2D, and insulin in the top quartile .of the . 
background population. Insulin in the top quartile of the background population 
· and IFG but not diabetes was utilized in the EGIR definition, and I FG and 
diabetes in the AHA/NHLBI (NCEP) definition (See Table 1). Second, the most 
recent NHANES did not collect data on hip measurements. We utilized only the 
BMI data for our obesity value in the WHO definition. Third, gestational diabetes 
data, and lastly, data on polycystic ovary syndrome were not available for women 
who may have had a history of these two conditions. Thus, in the ACE/AACE 
high-risk requisite criteria we only included 1) family history of CVD, 2) known 
CVD, 3) inactive lifestyle , 4) over 40 years of-age, and 5) ethnic populations at · 
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high-risk for T2D. Another limitation is the cross-sectional nature of our study, 
precluding causation from being inferred. 
Conclusion 
In conclusion, the magnitude of Mets prevalence is highly dependent on 
the medical society definition used. Thus, direct ·comparisons of prevalence 
values across Mets studies may be severely limited. Future studies should 
carefully consider which medical society definition to adopt in order to maximize 
their ability to relate to findings from other studies. In addition, our study ·may also 
assist researchers to anticipate the magnitude of the expected prevalence they 
will encounter in study populations based on the definition adopted, thus allowing 
them to refine project methodologies (i.e. power analysis). Furthermore,· this 
study will allow practitioners and researchers to continue dialogue· which may 
lead to a consensus on which def_inition would be the best to employ· in both 
clinical and research environments. 
1 80 
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APPENDIX B 
Metabolic Syndrome and its Relationship to Total Physical Activity: 
NHANES 1999-2002. 
1 9 1 
Abstract 
In the past, the examination of the relationship between physical activity .(PA) 
and the metabolic syndrome (MetS) has been restricted to leisure-time 
physical activity. The 1999-2002 National Health and Nutrition Examination 
Survey (NHANES I V) currently assesses PA across all . domains (leisure-time, 
destinational , and domestic), allowing the .Mets to be examined from a global 
perspective. Purpose: To explore the relationship between total PA (leisure- . . 
time, destinational, and domestic) and the Mets among a national sample of 
adults. Methods : This study included 4059 adults, 20 years and older who 
completed the mobile examination center (MEC) examination in NHANES I V  . 
. Mets was defined based on the current National Cholesterol Education 
Program-Adult Treatment Program Ill criteria. Each subject completed a PA · 
interview that measured all domains of .PA, and included the assessment of 
intensity, frequency, and duration. Results :  The national age-adjusted . 
prevalence for the Mets was 32.4%. Prevalence of the Mets among adults 
meeting the ACSM/CDC recommendation was 21.8% .(met recommendation) , 
30.2% (insufficient), and 36.9% (physically inactive), demonstrating an 
inverse relationship. Adults with the Mets performed significantly less PA 
(827 MET-minutes per week) compared to those without the Mets (1076 
MET-minutes per week). However, there was not a significant difference 
between frequency of PA (per week) and PA duration (daily minutes), 
suggesting that exercise intensity may be the best explanation for explaining 
the difference adults with and without the Mets relative to the ACSM/CDC 
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recommendatJon. Conclusion: Those with Mets are less likely to meet 
ACSM/CDC recommendations for PA. Those with the Mets achieve less PA 
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Figure B-1 . Inverse association of physical activity and the metabolic syndrome 
when measuring physical activity from the parameters of the CDC/ACSM 
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Figure 8-2. Inverse association of physical activity when examining 
MET·min·wk·1and the risk of the metabolic syndrome in the United States adult 
population aged �20 years in NHANES 1999-2002. 
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AP�ENDIX C 
Alternate Findings: The Association of Total Physical Activity with 
the Metabolic Syndrome . . . 
1 96 
Abstract 
This study also took a preliminary look at a more global physical activity 
(PA) measure utilizing information on PA from three domains (LTPA, domestic, 
and transportation) .  Data utilized to measure total PA was accessed from two 
distinct NHANES questionnaire data files - the 'Physical activity' data file 
(PAQ_C) and the 'physical activities individual activities file' (PAQIAF) ( 1 ). The 
PAQ_C asked questions related to the frequency, intensity, and duration specific 
to transportational and domestic PA performed ovenhe past-30 days (e.g. Over 
the last 30 days, how often did you walk or cycle as a part of getting to or from 
work, or school, or to do errands?). The PAQIAF is the second of the two files on 
PA and includes more detailed information regarding 43-specific types of 
moderate and vigorous L TP A. The combination of information from the two PA 
files allowed us to create a global measure of PA to examine the possible inverse 
association with metabolic syndrome risk. Appendix C includes replicate tables 
also found in Part IV. 
Table C-1 illustrates the prevalence of the metabolic syndrome according . 
to the American Heart Association and National Heart, Lung, and Blood Institute 
(AHA/NHLBI) definition by the Centers for Disease Control and Prevention and 
the American College of Sports Medicine (CDC/ACSM) public health PA 
recommendation and total weekly MET·minutes from all three domains of PA. 
The prevalence of the metabolic syndrome among those meeting the current 
CDC/ACSM PA recommendation (3) was 33.0% (95% Cl 30.0-36.0) . The 
prevalence among those reporting no PA (inactive) from any of the three 
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domains was 41.6% (95% Cl 38.0-45.3), significantly greater than those meeting 
the current public health recommendation. 
Table C-2 depicts the relative risk odds ratio (OR) of a metabolic 
syndrome diagnosis and the accumulation of increasing the metabolic risk score 
(MSRS) by total weekly MET·minutes. Interestingly, we found an inverse 
association (OR 0.76; 95% Cl 0.58-0.98) beginning at a volume of 1261.18 
weekly MET-minutes, a much greater level than that found when examining the 
results of Part I V  which solely focused on L TPA (OR 0.65; 95% Cl 0.48-0.88) 
(736.55 weekly MET·minutes). A similar inverse association was found for 
increasing the MSRS (OR 0. 79; 95% Cl 0.64-0.96). 
Table C-3 depicts the OR of a metabolic syndrome diagnosis and the . . . 
increasing metabolic risk score MSRS by the CDC/ACSM public health PA 
recommendation when focusing on total weekly MET·minutes. Those meeting 
the current public health PA recommendation were found to be 31 % (OR 0.69; 
95% Cl .057-0.84) less likely to have the metabolic syndrome and 25% less likely 
(OR O. 75; 95% Cl 0.64-0.88) to add an add itional risk factor to the MSRS 
compared to those reporting no PA (inactive) from any of the three domains. 
These associations were similar to those found in Part I V  when examining LTPA; 
however, the inverse relationships were n·ot as strong. This too warrants future 
study. 
One possible explanation for these conflicting results between L TPA and 
Total PA resides with intensity of PA. Table C-4 compares the proportion of 
vigorous MET-minutes among those who reported strictly L TPA and those 
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reporting PA from up to all three domains. When examining the rirst two levels.of 
PA, approximately 10%-15% of the weekly MET·minutes come from vigorous 
activities for L TPA and total PA. However, as the volume of L TPA MET·minutes 
increases, the proportion of those MET·minutes coming from vigorous PA also 
increases. Those accumulating the greatest volume of L TPA (>1360.15 
MET·minutes) acquired 45.7% of their MET-minutes from vigorous PA. Those 
accumulating the greatest volume of total PA (2298.66 MET-minutes) only 
acquired 27.6% of their MET·minutes from vigorous PA. 
The level and appearance of protection associated with PA and the 
metabolic syndrome clearly differs when examining multiple domains (L TPA, 
domestic, and transportation), versus one domain,· in this case L TPA. Perhaps· 
the reason Ford et al. in an earlier NHANES metabolic syndrome and PA study 
. (2) did not find protection associated with PA was because he utilized multiple 
domains (L TPA and domestic). These data suggest intensity, one ·of the 
parameters of PA volume, may play an important role in .the relationship between 
PA and the metabolic syndrome. Future studies need to examine all these . 
parameters to elucidate which of these components may be related to these 
conflicting outcomes. This type of information may assist health care 
professionals to understand how to prescribe PA to people for prevention and 
disease control specific to the metabolic syndrome. 
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Table C-1. Metabolic Syndrome Prevalence According to the AHA/NHLBI 
Definition by CDC/ACSM Public Health PA Recommendation* and Total PA 
MET·Minutes from All Three Domainst Among U.S: Adults �20 Years - NHANES 
1999-2004. 
Weekly L TPA MET minutes 
0.0 
>0.0 - �283.43 
>283.43 - �675.48 
>675 .48 - �1 261 . 1 8  




















37.3 ,  45.5  
32.6, 39. 8 
31 .3 ,  39.3 
30.5 ,  38. 1 
27. 1 ,  35.0 
95%-CI 
38.0, 45. 3 
35.9, 40.4 
30.0, 36.0  
CDC/ACSM=Centers for Disease Control and Prevention / American College of Sports Medicine. 
MET=Metabolic equivalent (1 MET= 3.5 mVkg/min-1) 
• Every us· adult should accumulate 30 minutes or more of moderate-intensity physical activity on most, preferably 
all, days of the week (3). 
t PA from L TPA, domestic PA, and transportational PA. 
;Physically active but insufficient to meet CDC/ACSM recommendation (3). 
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Table C-2. Odds ratios of Metabolic Syndrome diagnosis and Increasing , 
Metabolic Syndrome Risk Score (MSRS) by Weekly MET-minutes from All Three 
Domains of PA*: NHANES 1999-2004. 
Metabolic syndrome risk by Risk of increasing 
total PA level MSRS 
P value 
Weekly MET minutes Odds ratio 95% CI for trend Odds ratio 95% CI 
0.0 1 .00 0.0006 1 .00 
>0.0 - �283.43 1 . 1 5  0.88, 1 .51 1 .27 1 .00, 1 .61  
>283.43 - �675.48 0 .84 0.66, 1 .08 0.92 0.73, 1 . 1 5  
>675.48 - �1 261 . 1 8  0 .85 0.66, 1 . 1 0  0.91 0.73, 1 . 1 4  
>1261 . 1 8 - �2298.66 0.76 0.58, 0 .98 0.79 0 .64, 0.96 
>2298.66 0.64 0.49, 0.83 0.69 0.57, 0.84 
Covariates adjusted for in the model include gender, age, race/ethnicity, education, income, smoking status, 
alcohol intake, family history of heart disease, and family history of diabetes. 
MET=Metabolic equivalent (1 MET= 3.5 mVkg/min-1 ) 





Table C-3. Odds ratios of Metabolic Syndrome diagnosis and Increasing Metabolic 
Syndrome Risk Score (MSRS) by CDC/ACSM public health PA recommendation· and . · 
Total PA from All Three Domainst: NHANES 1999 .. 2004 
LTPA Level 
Metabolic syndrome risk by 
total PA level 
Odds ratio 95% Cl 
Risk of increasing 
- MSRS 
Odds ratio 95% CI P value P value 
for trend for trend 
Inactive 
Insufficiently active; 




0.71 , 1 .09 
0.57, 0 .84 
· 0.001 0 1 .00 -
0.98 0 .81 , 1 . 1 8  
0.75 0 .64, 0.88 
Covariates adjusted for in the model include gender, age, race/ethnicity, education, income, smoking status, 
alcohol intake, family h istory of heart disease, and family history of diabetes. 
CDC/ACSM=Centers for Disease Control and Prevention / American College of Sports Medicine. 
CV= Cardiovascular disease. 
• Every US adult should accumulate 30 minutes or more of moderate-Intensity physical activity on most, preferably 
all, days of the week (3): 
t PA from L TPA, domestic PA, and transportational PA. 
; Physically active but insufficient to meet CDC/ACSM recommendation (3). 
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0.001 5 
Table C-4. Proportion of Vigorous Intensity PA Comparing Total 
PA from All Three Domains* and PA from those Reporting Only 
LTPAt : NHANES 1999-2004. · · 
LTPA MET·minutes 
% _from % from 
vigorous PA vigorous PA 
0.0 
>0.0 - �1 56.24 1 0.0 
>1 56.24 - �393. 1 0  1 5.8 
>393. 1 0  - �736.55 24.8  
>736.55 - �1 360. 1 5  34.5  
>1 360. 1 5  45.7 
*PA from L TPA, domestic PA, and transportational PA. 








Weekl  MET minutes 
0.0 
>0 .0 - �283 .43 
>283.43 - �675.48 
>675.48 - �1 261 . 1 8  
> 1261 . 1 8  - �2298.66 
>2298.66 
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